CURRICULUM VITAE January 5th, 2014

CURRICULUM VITAE January 5th, 2014

1

Name: ROBERT C. G. MARTIN, II, MD, PHD

Office address: Division of Surgical Oncology

University of Louisville

315 East Broadway, #313

Louisville, KY 40202

Phone: (502) 629-3355

Fax: (502) 629-3030

E-mail: [email protected]

Home address: 3705 Pennington Lane

Louisville, KY 40207

Date of Birth: May 16, 1968

Place of Birth: Louisville, Kentucky

Marital Status: Married: Sarah P. Martin, MeD

Children: Cora H. Martin

Clare V. Martin

Christine J. Martin

Education: Georgetown University 1986-1990

Major: Mathematics

Washington, DC

Degree: BSc

University of Louisville School of Medicine 1991-1995

Louisville, Kentucky

Degree: MD

University of Louisville School of Medicine 2003-2008

Department of Pharmacology and Toxicology

Louisville, KY

Degree: PhD

Endowed Professorship: Sam and Lolita Weakley Endowed Chair 2011- Present

in Surgical Oncology

Department of Surgery


Faculty Appointments: Graduate Research Training Faculty 10/13-Present

Compaq_Owner

Note

https://sharepoint.louisville.edu/sites/bcc/faculty/Faculty%20CV/Martin%20CV.pdf


2

Member of the Graduate Faculty

University of Louisville School of Medicine

Associate Professor of Pharmacology & 9/2013-Present

Toxicology


J. Graham Brown Cancer Center

Professor of Surgery 7/2011-Present




Louisville, KY

Director 4/2008-Present

Division of Surgical Oncology



Louisville, KY

Associate Professor of Surgery 7/2007-6/2011




Assistant Professor of Surgery 7/2002- 6/2007




Internship: University of Louisville Hospital 1995-1996


Surgery

Residency: Department of Surgery 1996-1999



Chief Administrative Resident: Department of Surgery 1999-2000




3

Fellowship: Surgical Oncology Fellow 2000-2002

Memorial Sloan Kettering

Hepatobiliary Fellow 2001-2002

Memorial Sloan-Kettering

Certification: American Board of Surgery - #46569 10/29/2001

Recertified 12/11/2010

Licensure: Kentucky- #32503

New York - #218879

Honors/Awards: Charles M. Edelen Award

Best Publication by a Resident 2000

John W. Price Award

Excellence in undergraduate instruction 2000

William L. Brohm Award

Outstanding Overall Performance Resident 2000

Career Development Award

The Society for Surgical of the Alimentary Tract 2004-2006

Hiram C. Polk, Jr. Surgical Award

Resident Education chosen by the graduating

Chief Residents 2006

Nominated “Faculty Favorite”

Delphi Center for Teaching/Learning 2007

America’s Top Surgeon

Best Doctor 2007-2008 2008

Patients' Choice Award

Nation's most beloved doctors, patients 2008

2009 Top Doctors

Louisville Magazine! 2009

Who’s Who in America 2009

2009 Patients Choice Physician 2009


4

Cancer Liaison Physician (CLP)

Outstanding Performance Award 2010

America’s Top Oncologist

Honor of Distinction and Excellence 2010

America’s Most Compassionate Doctors 2010

America’s Top Surgeons 2011-2012 2011-2012

Best Doctors

Louisville Magazine 2012, 2013

Alpha Omega Alpha Honor Medical 2012

Society

Best 2011 JOGS Best Article Award Winner 2012

Analysis of 6,747 Pancreatic Neuroendocrine

Tumors for a Proposed Staging System

69th Samuel David Gross Lectureship 2013

Chemoprevention in Esophageal and

Hepatocellular Cancer

National Committees:

Southeastern Surgical Congress 1998

Continuing Medical Education Comm 2009-2013

Chair Program and CME Committee 2013-2014

Society of American Gastrointestinal

Endoscopic Surgeons 1998

American Medical Association 1991

American Hepato-Pancreato-Biliary Association 2002

Membership Committee 2005-2007

Development Committee 2007-present

International Relations Committee 2008-present

Chair, Professional and Development 2010-2012

Committee

Executive Council Member 2010-Present


5

International Hepato-Pancreatico-Biliary

Association 2009-present

Corporate Relations Committee 2009

The Society for Surgery of the Alimentary Tract 2000

Hepatobiliary Program Committee 2010

The Society of Surgical Oncology 2000

Training Program Directors Subcommittee 2006

Website Committee 2008

Chair of the Corporate Relations Committee 2009-Present

Continuing Medical Education Committee 2009

Chair of the Needs Assessment/Practice 2011-2013

Gaps Workgroup

Executive Council Member 2013-2016

James Ewing Foundation

Treasurer 2011-Present

The American Society of Clinical Oncology 2000

American Association for Cancer Research 2002

American College of Surgeons Oncology Group

Physician Group Leader 2003

Fellow 2004

Member 2000

Association for Academic Surgery 2004

The Leadership Council 2008-2010

Ethics Committee 2011-2013

The Society of University Surgeons 2005

The Membership Committee 2010-2013

The Western Surgical Association 2005

The Southwestern Surgical Congress 2008

The Southern Surgical Association 2008

The Central Surgical Association 2008

Program Committee 2012-Present


6

The American Association Surgical Association 2012

The Cholangiocarcinoma Foundation Medical

Advisory Committee 2013

Local/State: Jefferson County Medical Association 1995-present

Georgetown Alumni Admissions 1998-present


Admissions Committee 1992-1995

Graduate Medical Committee House Staff

Council 1999-2000

Kentucky Medical Association 1991-present

Manpower Committee 1991-1994

Cancer Committee 2002-present

Chairman 2006-present

Hiram C. Polk Surgical Society 2000-present

Secretary 2009-present

Louisville Surgical Society 2002-present

President 2011

Cancer Liaison University of Louisville Hospital 2002-present

James Graham Brown Cancer Center

Cancer Committee 2002-present

Chair Subcommittee: 2003 BCC Annual Report 2004

Chair Subcommittee: Conferences 2004-present

Cancer Prevention and Control Program 2003-present

Physician in Charge Tumor Board 2002-present

The American Cancer Society

Colorectal Screening Committee 2003-present

Kentucky Physician’s Workgroup 2004-Present

Norton Health Care

Director Upper Gastrointestinal & Hepato-

Pancreatico-Biliary Conference Norton Hospital 2004-present


7

Cancer Liaison Norton Hospital

Committee on Cancer 2002-present

Cancer Liaison Outstanding Performance

Award 2010

Leadership: Network Designation Committee

on Cancer 2005-2006

Physician Advisory Committee

Colonoscopy Screening Initiative 2006-present

Norton Cancer Institute Advisory Board 2007-present

Center for Genetics and Molecular Medicine:

Genetic Susceptibility and Biomarkers Core 2004-present

Director Upper Gastrointestinal and

HepatoPancreaticoBiliary

Multidisciplinary Clinic and Conference

James Graham Brown Cancer Center 2005- present


Resident Conference Director 2005-Present

University of Louisville Hospital

Medical Staff Bylaws Committee 2006

Director of Surgical Resident Curriculum 2005-2010

Co-Director Surgical Oncology Journal Club for

Surgical Residents 2004-Present

Director Upper Gastrointestinal and Hepato-

Pancreatico- Biliary Multidisciplinary Clinic

and Conference James Graham Brown Cancer

Center 2005-Present

Co-Director of the Society of Surgical Oncology

Accredited 2-Year Surgical Oncology

Fellowship Program 2005-Present

One Hour Lectures on Liver and Spleen to Third Year

Medical Students Each 8-Week Surgery Rotation 2002-2010


8

One Hour Lecture on Pancreas to Third

year Medical Students Each 8-Week

Surgery Rotation 2002-2010

Participate in Third Year Oral Exams Each

8-Week Surgery Rotation 2002-Present

Journal Club for Senior Honors Students 2003

Mentoring:

Name of

Mentees

Medical Student,

Resident, Fellow,

Pre- or Post-doc Training Period Prior Academic Degree Title of Research Project(s) Current Position

Ryaz Chagpar Pre 6/25/2005 to

9/1/2005

BS

MSc

2003 University of

Saskatchewan

Factors associated with

improved survival among

young adult melanoma

patients despite a greater

incidence of sentinel lymph

node metastasis.

Surgical Resident,

University of

Vancouver, British

Columbia

Angela Michelle

Lewis

Post 07/01/05 to

06/30/07

BS

MD

1999

2000

Temple University Analysis of DNA adducts

and DNA damage in

thyroid disease and thyroid

cancer

Private practice, The

Portland Clinic,

Oregon, Surgical

Oncology

Charles E. Woodall Post 07/01/06 to

06/30/08

BLA

MD

Dec 2000

May 2001

University of

Missouri-Kansas

City

Accurate nodal staging and

imaging characteristics to

predict overall survival

Instructor, Endoscopy

(ERCP), Department

of Surgery,

University of


Nathan Reuter Post 07/01/2007 to

06/30/2009

BA

MD

May 1998

May 2002

University of North

Dakota

Use of adjuvant

chemotherapy in young

women with node-negative

ER+ breast cancer: refining

the use of recurrence score -

a decision analysis.

Current Surgical

Oncology Fellow,

Source of Support is

James Graham Brown

Cancer Center,


Matthew R. Bower Post 07/01/2008 to

06/30/2010

BS

MD

May 1999

June 2003

University Texas

Southwestern

Chemoprotective Effects of

Curcumin in Esophageal

Epithelial Cells Exposed to

Bile Acids

Current Surgical

Oncology Fellow,

Source of Support is

James Graham Brown


9

Cancer Center,


Christine Landry Post 7/1/2004 to

7/1/2008

MD (resident) 2008 University of

Louisville

Analysis of carcinoid

tumors

Surgical Oncology

Fellow, MD

Anderson, Houston,

Texas

Harini Aiyer Post 2007-2011 PhD 2007 University of

Kentucky

Prevention of reflux-

induced esophageal

adenocarcinoma by dietary

berries

Research Postdoc,

Georgetown

University

Yan Li Post 2003-current MD, PhD 1998 Cheng Du University

of Chinese Medicine

Optimal Esophageal

Animal Modeling

Current Assistant

Clinical Professor of

Research

Division of Surgical

Oncology

Kalista Hughes Med Student 6/1/03-8/15/03 BS 5/2002 UL MnSOD and Gastric Cancer Internal Medicine

Resident

Amanda Bressler PGY1 7/1/07 to 6/30/08 M.D.

BS

5/2007

2002

UL

UK

MnSOD expression in

Pancreatic Cancer

Ob/Gyn Resident –

Good Samaritan -

Cincinnati, Ohio

Ryan Duvall Med Student 6/1/2007-

8/15/2007

BS 5/2005 UL

Jennifer Lohle Med Student 6/1/2006-

8/15/2006

BS 5/2004 UL Kentucky Hepatoma:

epidemiological variant or

same problem different

region?

Ob/Gyn Resident –

Good Samaritan -

Cincinnati, Ohio

Ryan Whitney Med Student 1st-4th 6/15/2008-

Present

BS 5/2007 UL The Use of Self-Expanding

Silicone Stents in

Esophageal Strictures: Less

Cost and More Efficiency

Current Third Year

Medical Student

Jonathan Joshi Post Med School 1 6/1/2008-7/1/2009 MD 5/2008 UL Hepatic Intra-arterial

injection of Irinotecan Drug

Eluting Beads in

Unresectable Colorectal

Liver Metastatic Refractory

to Standard Systemic

Chemotherapy: Results of

PGY-1 Department of

Radiology


10

Multi-Institutional Study

Bruce Herrmann Res 07/1/02 to

6/30/07

M.D.

BS

2002

1998

Texas Tech

Baylor University

Association of Manganese

Superoxide Dismutase

Expression with

Progression of

Carcinogenesis in Barrett’s

Esophagus.

**Charles M. Edelen

Award Winner: Best

publication by a resident.

Plastic Surgery

Fellowship – UT

Chattanooga (07-09)

Vedra Augenstein Res

07/1/05 to

6/30/10

MD

BS

2005 UL

UL

The Quality of Survival

Reporting in Chemotherapy

and Surgery Trials in

Metastatic Colorectal

Cancer.

**Publication: Cancer

2006;106:1389-1394.

PGY-5 Chief Surgical

Resident

Sebastian Eid Res

07/1/05 to

6/30/10

MD

BS

2005

2001

UL

UL

Assessment of symptom

experience in patients

undergoing hepatic

resection or ablation.

**Publication: Cancer

2006;107:2715-2720.

PGY-5 Chief Surgical

Resident

Chinmaya Shelgikar Res 7/1/ 2001 to

6/30/07

(research year at

Emory 7/04

to7/05)

MD

BS

2001

Medical College of

Wisconsin

Univ of Wisc, Mad

Empiric Antibiotics for

Transarterial Embolization

in Hepatocellular

Carcinoma: Indicated?

**Publication: Am Surg

2007

Private Practice, Ann

Arbor, MICH

Benjamin Vessels Res 7/1/2008 –

5/15/2009

BS 2003 UL The role of esophageal

stents in the nutritional

support of patients with

esophageal malignancy

Resident

Russell Brown Fellow 7/1/2009 –

1/1/2010

MD Theramal Resistance

Effects of Hepatocellular

Second Yr Surg Onc

Fellow UL


11

Cancer

Nick Harper Undergraduate 5/3/2010 –

8/15/2010

BS – Pending 2011 Bellarmine EGFR expression in

Barrett’s Esophagus

Daniel Malik Undergraduate 5/15/2009 –

5/5/2010

BS – Pending 2011 UL MnSOD expression in

smoke exposed Barrett’s

Esophagus

Andrew Ramsey Medical Student 1st 6/1/2010 –

8/12/2010

MD- Pending 2014 UL BMI as a predictor of

outcomes following

pancreatectomy

Suzanne Schiffman Resident – PGY3

Research Fellow

7/1/2009 –

6/30/2010

MD 2007 U of Pitt Intrahepatic

Cholangiocarcinoma and

molecular predictors of

ourcome

Surg Onc Research

Fellow

Charles R. St. Hill Surgical Oncology

Fellow

7/1/2010 –

6/30/2012

MD 2005 U Nevada Las Vegas Efficacy of LEDC Ablation

on Human Pancreatic

Adenocarcinoma in a

Murine Model

Assistant Professor of

Surgery UNLV

Russell Farmer Resident – PGY3 7/1/2010-

6/30/2011

MD 2004 U of Texas Surg Onc Research

Fellow

Mohsen Hasanin Medical Student 11/1/2010 –

12/31/2010

MD 2010 Cairo University Surgical Oncology

outcomes

Surg Onc Medical

Student rotation

Amanda Miller Medical Student 5/14/2011-

8/12/2011

BS 2004 Quality if life after major

hepatectomy

Second Year Medical

Student

Nsehniitooh Mbah Medical Student 5/14/2011-

4/12/2014

BS 2004 3 publications: Optimal

Transection for

Laparoscopic Liver

Second Year Medical

Student

Robert M Cannon Resident – PGY 2 –

Research

3/4/2011 –

6/30/2012

MD 2007 U of Georgia 5 Publications:

Laparoscopic Liver

Resection

Third Year Surgical

Resident

Thomas Lee Resident – PGY 2 –

Research

5/4/2011-

6/30/2012

MD 3 Publications: Quality

Factors in Readmission

following Surgical

Oncology Procedures

Third Year Surgical

Resident

Matthew Fox Resident – PGY3 –

Research

5/5/2010-

6/30/2011

MD 3 Publications: Optimal

Surgical Outcomes in

Pulmonary Carcinoids

Fourth Year Surgical

Resident


12

Eric Dunki-Jacobs Surgical Oncology

Fellow

7/1/2011-

6/30/2012

MD U of Cincinnati First Year Surgical

Onc Fellow

Rafi Kotoyan Third Year Medical

Student

5/5/2011-

12/2/2012

MD Hepatic Arterial Therapy in

Met Pancreatic Cancer

General Surgery

Resident UNLV

Scott Tatum Third Year Medical

Student

5/5/2011 –

12/2/2012

BS

MD

2012

U of Louisville

Hepatic Arterial Therapy in

Met GE Junction Cancer

Radiology Resident

Rhodes Brown Undergraduate 6/2012-8/2012 BS (pending) 2013 William and Lee

College

Optimal Management of

Liver Dominant Breast

Cancer

Undergrad Student

Nicholas Burnett First Year Student 6/2012-8/2012 BS

MD

2011

2015

U of Louisville

Optimal Staging in HCC

Pubs Below:243

R25 NIH Summer

Student

Ryan Anderson First year Student 6/2012-8/2012 BS

MD

2011

2015

U of Louisville

Pancreatic fistula

prevention with

somatostatin

R25 NIH Summer

Student

Vanessa States Undergraduate 6/2012- 8/2012 BS R25 NIH Summer

Student

Jacob Edwards First Year Medical

Student

9/12 to 5/13 BS 2011 Combined Liver and

Pancreatic Resections:

Safety and Outcomes

Elizabeth

Bruenderman

First Year Student 6/2013-5/2014 BS Optimal Pancreatic

Screening and Cost for

Pancretic Adenocarcinoma

Prevention

R25 NIH Summer

Student

Alan North First Year Student 6/2013-5/2014 BS 2012 Microwave Ablation:

Optimal quality and

presentation

R25 NIH Summer

Student

John Wehry First Year Student 6/2013-5/2014 BS 2012 Allogenic Blood

Transfusion in Surgical

Oncology

R25 NIH Summer

Student

Xuanyi (Selina) Li Pre-Doctoral Student 6/2011-6/2014 BS 2010 Ohio State

University

Berry Gavage and Liver

protection

Dental Student

Alexandria Oliver Pre-Doctoral 1/2014-7/2015 BS 2012 Mercer University PK data for DEBDOX use Masters

Biophysiology

Dissertation Committee Work:

Chair Dissertation Committee for

2008 Masters Program: 2008


13

Charles W. Woodall, MD: Research proposal

Yttrium-90 Intra-Arterial Brachytherapy

for Unresectable Hepatocellular Cancer with Portal

Vein or Inferior Vena Cava Thrombosis:

Safe and Clinically Beneficial?

Member Dissertation Committee for

2008 Masters Program: 2008

Benjamin Vessels, MD: Research Proposal

The Multidisciplinary Use of Esophageal Stenting

Mentor of PhD Doctoral Candidate Pharmacology

and Toxicology: Harshul Pandit 2013-

Present

Clinical Service Activities: Director Upper Gastrointestinal and Hepato

Pancreatico-Biliary Multidisciplinary Clinic

And Conference

James Graham Brown Cancer Center 2005-

Present

Establishing an specialized practice in Upper

Gastrointestinal and Hepato-Pancreatico-Biliary

Cancers with RVU average billing of

15,750 per year (> 95% benchmark averages for

Surgeons) 2002-

Present

Established TheraSphere program for

Unresectable Hepatocellular Cancers and

Compassionate Use for Metastatic Cancers

To Liver 2004-

Present

Established the only intraoperative MRI-guided

Liver ablation center in the region 2002-2005

Established only Microwave Ablation Center in

Region 2003-

Present


14

Established only LC Bead, Drug-Eluting Bead

Treatment Center in region 2005-

Present

Course Director: Laparoscopic Liver

Resection Course – Nine visiting surgeons

From the United States attended to learn my

Technique of laparoscopic liver resection November

9, 2007

Invited Faculty: Advanced Upper Abdominal

& Bowel Cadaver Surgery

Instructed 17 gynecologist oncologists in

Hepatic resection, ablation and bowel resection

Techniques May 17-

18, 2008

Course Director: First Ever Microwave Ablation

Course: Basic physics Preoperative, intraoperative

And Postoperative techniques

Twenty visiting surgeons and interventional

Radiologists/oncologists from the United States April 15,

2008

Attended to learn my technique of microwave June 20,

2008

Ablation – Three separate courses August 15,

2008

Course Director: Microwave Ablation and

Ultrasound Workshop

Trained 21 separate surgeons on advanced

Hepatic ultrasound and microwave ablation July 22-24,

2009

Course Director of the Only Irreversible


15

Electroporation Physician Training Workshop:

2009: October 10th, 2009, November 11th, 2009,

2010: February 12th, 2010, February 19th, 2010, March 26th,

2010, May 7th, 2010, May 21st, 2010, Sept 4th, 2010, Oct

15th, 2010, Nov 3rd, 2010, Nov 12th, 2010, Dec 17th, 2010,

2011: 1/7, 2/11,2/22, 3/1, 3/25,5/20, 6/17, 7/8, 8/26, 9/30,

10/14, 11/4, 12/9

- Total trained 95 Surgeons/ Interventional Oncologist from the

United States and Taiwan on the Pre-Clinical, Clinical, and

Hands on Use of Irreversible Electroporation in the Non-

Thermal Soft Tissue Ablation

2012: 1/13, 2/24, 5/18, 5/25, 6/19, 8/24, 10/5, 11/16, and 12/14

- Total of 100 Surgeons/ Interventional Oncologist from the


Hands On Use of Irreversible Electroporation In the Non-


2013: Jan, Feb, March, April, May, June, July, August, Sept,

Oct, Nov, and Dec

- Total of 75 Surgeons/ Interventional Oncologist from the


Hands On Use of Irreversible Electroporation In the Non-


Course Director of the Only Irreversible Electroporation

Human Case Observations:

2010: Aug 4th, 2010, Sept 22nd, 2010, Oct 13th, 2010, Nov

3rd, 2011, Dec 1st, 2010

2011: 7/27, 8/24, 9/7, 9/28, 10/12, 11/2, 12/7

-Total of 60 Surgeons trained the actual use and safety of the

device from The United States, France, and Japan

2012: 1/11, 2/29, 5/23, 7/11, 8/22, 9/26, 10/24, 11/14, and

12/12

-Total of 45 Surgeons trained the actual use and safety of the

device from The United States

2013 : Jan, Feb, March, April, May, June, July, August, Sept,

Oct, Nov, and Dec

- a total of 48 Surgeons from USA, Denmark, Czech Republic,

and other European Countries trained for the Actual use and

Safety of the Device in the United States : Jan, Feb, March,

April, May, June, July, August, Sept, Oct, Nov, and Dec

- a total of 48 Surgeons trained for the Actual use and Safety of

the Device in the United States


16

Co-Course Director of Laparoscopic Liver, Pancreatic, Gastric

and Esophageal Surgery Human Case Observation Course:

2012:

- Total of 12 Surgeons from across the United States have

traveled to observe and learn minimally invasive techniques for

laparoscopic liver, pancreatic, gastric and esophageal

resections.

RESEARCH FUNDING:

Grants Completed

1. Role: Principal Investigator 3/13/2003 Codman: Johnson and Johnson

Unrestricted Educational Grant for Hepatobiliary Disease Management Team and

Screening. $15,000

2. Role: Principal Investigator 7/1/2003-6/30/2004

James Graham Brown Cancer Center: Cancer Research Pilot Projects.

Genetic Polymorphisms in Manganese Superoxide Dismutase (MnSOD) as a Predictor

of Lung Cancer. $31,596.


James Graham Brown Cancer Center: Microarray Pilot Project Program.

Expression Profiles of Barrett’s Esophagus using Laser Capture Microdissection:

Evaluating Predictors for Malignancy. $30,000.


Society for the Surgery of the Alimentary Tract: Career Development Award.

Oxidative Stress in the Progression of Barrett’s Esophagus to Adenocarcinoma

Utilizing a Novel External Esophageal Perfusion Model. $80,000.

5. Role: Co- Investigator 7/1/2004-6/30/2006

Pharmacogenetics of drug and carcinogen metabolism.

Activities to Promote Research Collaborations: supplement to NCI parent

grant (R01-CA34627). $113,750.

6. Role: Principal Investigator 5/1/2006 – 9/30/2006

James Brown Cancer Center MicroPet Pilot Project

Evaluation of Barrett’s Metaplasia and Esophageal Adenocarcinoma by Micro-PET

Scan in Esophagoduodenal Anastomosis Rat Model. $30,000.

7. Role: Principal Investigator 7/1/2006 – 10/30/2006


17

School of Medicine Grant

MnSOD Therapy in the prevention of adenocarcinoma in a rat model of

Barrett’s esophagus. $15,000.

8. Role: Principal Investigator 10/1/2008 to 9/30/2010

NIH RO3 CA137801-01

Prevention of Reflux Induced Esophageal Adenocarcinoma by Dietary

Berries. $145,000

9. Role: Principal Investigator Robert C.G. Martin 7/1/2010 – 12/31/2011

CLINICAL AND TRANSLATIONAL SCIENCE PILOT GRANT PROGRAM

Title of Innovative Award: Validated Animal Model to Identify Novel Predictors

of Barrett's Progression into Cancer $175,000

10. Role: Co-Principal Investigator 3/29/2010 to 4/30/2012

Wallace H Coulter Foundation

Chitosan Modified NIR Absorbing gold nanoparticles for increasing efficacy of

treatment of hepatocellular cancer $240,000

Current Grant Funding & Clinical Trials

1. Role: Principal Investigator 7/1/2007 to Present

Unrestricted Education Grant: AngioDynamics/ Biocompatibles

Evaluation of Precision Hepatic Arterial Therapy for Primary and Metastatic

Liver Tumors $1,650,000.

2. Role: Sponsor – Principal Investigator Co-Investigator 6/1/2010 – 6/30/2010

Biocompatibles Foundation

Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Unresectable

Intrahepatic Cholangiocarcinoma (ICC) with Concomitant Systemic Gemcitabine and

Cisplatin (Gem-Cis)

Pilot $32,100

Initial Phase 2: $126,000

Second Phase 2: $640,000

3. Role: Principal Investigator 10/1/2010 to Present

Unrestricted Education Grant: AngioDynamics/ Biocompatibles

Evaluation of Soft Tissue Ablation for Cancers $950,000

4. Role: Participating Faculty Mentor (PI: Hein DW)

University of Louisville Cancer Education Program


18

Funding Agency: NIH/NCI (R25-CA134283)

Project Period: September 14, 2011 to August 31, 2016

5. Role: Martin (PI) (Biocompatibles, Investigator Initiated) - 4/18/2009-12/31/2014

FDA: IDE Submission #G080230-S001

Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis from

Colon Cancer with Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin

chemotherapy, and anti-Angiogenic Therapy

Phase 1: $188,000

Phase 2: $1,250,000

6. Role: Martin (PI) (Sirtex Initiated Phase III Study) – 6/2006 to Present

Prospective Randomized Phase 3 Trial using Folfox-based chemotherapy in

combination with SirSphere® liver-directed radiation therapy to treat metastatic

colorectal cancer.

Phase III - $265,000

7. Role: Martin (PI) (MDS Nordion Phase II Study) – 1/2013 to Present

TS-102 trial is a randomized phase III study evaluating the use of Yttrium-90

drug eluting beads in combination with standard of care chemotherapy

(FOLFOX or FOLFIRI) versus chemotherapy alone.

Phase II - $295,000

8. Role: Martin (PI) (MDS Nordion Phase III Study) – 1/2013 to Present

This randomized phase III trial will evaluate the overall survival of Yttrium-90

drug-eluting beads in combination with sorafenib versus sorafenib alone in the

treatment of patients with unresectable hepatocellular carcinoma.

Phase III - $195,000

9. Role: Martin (PI)Investigator Initiated Study - 1/2013 to Present

GERD-Related Symptom Assessment in Subjects with Malignant Dysphagia

Receiving Esophageal Stents.

Pilot - $9000

Longer Term Study: $9000

Completed Clinical Trials

10. (Biocompatibles, Investigator Initiated) Martin (PI) - 10/1/2009-8/2012

FDA: IDE Submission #G090097/S001

Transcatheter arterial chemoembolization (TACE) with doxorubicin-loaded LC

beads in the treatment of liver metastases in patients with stage IV metastatic

melanoma: A multicenter pilot non-randomized, feasibility trial $467,000


19

11. (Bayer, Industry Sponsored) Martin (PI) - 9/1/2009-6/2012

A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant

treatment for hepatocellular carcinoma after surgical resection or local ablation”

(the “STORM – Adjuvant HCC study”) $197,000

12. (Bayer, Industry Sponsored) Martin (PI) - 3/1/2009-6/1/2011

HCC Non-Interventional Study –GIDEON

$65,000

13. (Investigator Initiated) Martin (PI) - 4/18/2009-12/31/2011

Clinical Evaluation of Neoadjuvant Gemcitabine, Docetaxel, and capecitabine

with Concurrent Radiation for Patients with Borderline/ Locally Advanced

Pancreatic Carcinoma

(Unfunded)

14. (ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011

A phase II study of preoperative and postoperative gemcitabine and erlotinib

for patients with operable pancreatic adenocarcinoma.

15. (ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011

A phase II study of neoadjuvant therapy with cisplatin, docetael, panitumunab

plus radiation therapy followed by surgery in patients with locally advanced

adenocarcinoma of the distal esophagus.

16. (Industry Sponsored, Investigator Initiated) Martin (PI) - 6/1/2008-12/31/2010

Clinical Evaluation of Polyflex Stenting in Esophageal Cancer patients Undergoing

Chemotherapy and/or Radiation therapy

$118,000


FDA: IND Submission (Martin) #08.0119 (NCT00955097)

Evaluation of intra-operative ultrasound contrast enhancement in the evaluation of liver

Tumors

(Unfunded)


FDA IND Submission (Martin) #CR012460, EPOSUR4005

A prospective, randomized, double blinded control study or procrit vs placebo to determine

efficacy in pre-operative patients undergoing major surgical oncology procedures. $129,000

19. (Industry Sponsored) Martin (PI) - 10/11/2008-12/31/2010

http://clinicaltrials.gov/ct2/show/NCT00955097


20

Selective Internal Radiation Therapy (SIRT) + 5-Fluorouracil, Leucovorin and OXaliplatin

[FOLFOX6m] vs. FOLFOX6m alone

$197,588


Effect of Reinforced Staple Line on Leak Rate in Distal Pancreatectomy

(Unfunded)

21. (Investigator Initiated) Martin (PI) - 4/3/2004- 8/2012

TheraSphere Hepatocellular Humanitarian Device Exemption Programs and Compassionate

Use Metastatic to Liver Program

(Unfunded)


Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy.


Norton Healthcare Community Trust Fund.

Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical

Oncology Operations.

$150,000.

24. (Vivant Medical, Investigator Initiated) Martin (PI) - 1/4/2004-10/31/2004

A Phase II study of Microwave Hepatic Ablation: Safety and Efficacy.

$50,000

25. (Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2004-10/15/2004

A Phase 2, Randomized, Double-Blind Study of the Safety and Efficacy of Topical

rhThrombin in Subjects Undergoing Partial Hepatectomy.

$110,000

26. (Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2006-6/15/2006

A Phase 3, Randomized, Double-Blind, Controlled Study of the Safety and Efficacy of

Topical rhThrombin (1000 U/mL) in Surgical Hemostasis.

$188,000

27. (University of Calgary, Investigator Initiated) Martin (PI) - 7/9/2007-6/30/2008

Randomized Control Trial Comparing the Effectiveness of a Web Based Journal Club

to a Standard Journal Club Format to Teach Critical Appraisal Skills.

$2000

Editorial Boards: The American Surgeon 2005-Present


21

Annals of Surgical Oncology 2009-Present

World Journal of Gastroenterology 2009-Present

Contributing Associate Editor-in-Chief 2011-Present

International Journal of Surgical Oncology 2009-Present

HPB 2010-Present

The American Journal of Surgery

Journal of Gastrointestinal Surgery

2012- Present

2011-Present

Invited Reviewer: American Journal of Surgery 1998-2005

Annals of Surgery 2008

Annals of Surgical Oncology 2005-Present

BMC Cancer 2006

Cancer Control: Journal of the Moffitt Cancer

Center

2005

Clinical Chemistry and Laboratory Medicine 2005

Clinical Cancer Research 2008

Cancer 2008

Critical Reviews in Oncology/Hematology 2006

Digestive and Liver Disease 2007

European Journal of Surgical Oncology 2006-Present

Endocrine Related Cancer 2006

Future Oncology 2006

International Journal of Cancer 2006

Journal of the American College of Surgeons 2002-Present

Journal of Surgical Research 2003

Journal of Clinical Oncology 2006

Medical Science Monitor 2005-2006

Mutation Research 2009

Southern Medical Journal 2002

Surgery 2006-Present

The American Surgeon 2004-Present

World Journal of Surgical Oncology 2007-Present

Peer-Reviewed Publications:

1. Spain DA, Martin RCG, Carrillo EH, Polk HC Jr. Twelfth rib resection: Preferred therapy

for subphrenic abscess in selected surgical patients. Arch Surg 132:1203-1206, 1997.

2. Seligson D, Howard PA, Martin RCG. Difficulty in removal of certain intramedullary

nails. Clin Orthop 340:202-206, 1997.


22

3. Flynn MB, Amin EA, Martin RCG. Mobile mammography screening: The James Graham

Brown Cancer Center three year experience. J KY Med Assoc 96:17-20, 1998.

4. Flynn MB, Greenwell D, Martin RCG. Value of preoperative localization studies prior to

initial neck exploration for hyperparathyroidism. J KY Med Assoc 97:255-260, 1999.

5. Martin RCG, Flynn MB. Initial neck exploration for untreated hyperparathyroidism. Am

Surg 66:269-272, 2000.

6. Martin RCG, Edwards MJ, Cawte TG, Sewell CL, McMasters KM. Basosquamous

carcinoma: Analysis of prognostic factors influencing recurrence. Cancer 88:1365-1369,

2000.

7. Martin RCG, Stutz JP. Multiple granular cell tumors of the gallbladder and biliary tree:

Literature review and case report. Gastrointest Endosc 51:238-240, 2000.

8. Martin RCG, Edwards MJ, McMasters KM. Giant cell tumor of tendon sheath,

tenosynovial giant cell tumor, and pigmented villonodular synovitis. Oncol Rep 7:413-419,

2000.

9. Martin RCG, McMasters KM, Wong SL, Tuttle TM, Edwards MJ. Optimal gamma probe

detection of sentinel lymph nodes in breast cancer: Results of a nationwide multi-institutional

study. Surgery 128:1-6, 2000.

10. Reed DS, Martin RCG, Vitale GJ. Bile duct carcinoma: Trends in treatment in the nineties.

Am Surg 66:711-715, 2000.

11. Flynn MB, Greenwell D, Martin RCG, Cerrito PB. Safety and effectiveness of methylene

blue infusion for intraoperative identification of parathyroid glands. J Surg Invest 3:227-233,

2001.

12. Martin RCG, McMasters KM. Presentation of histoplasmosis as an isolated liver lesion:

Case report and review. Am Surg 5:430-431, 2001.

13. Klodell CT, Martin RCG, Allen JW, Polk HC. Value of an advanced surgical technology

experience in the basic education of general surgical residents. Bulletin American College of

Surgeons 86:11-15, 2001.

14. Martin RCG, DeRossis AM, Fey J, Yeung H, Yeh SDJ, Akhurst T, Heerdt AS, Petrek J,

VanZee KJ, Montgomery LL, Borgen PI, Cody HS. Intradermal isotope injection is superior

to intramammary in sentinel node biopsy for breast cancer. Surgery 130:432-438, 2001.


23

15. McMasters KM, Wong SL, Martin RCG, Chao C, Tuttle TM, Noyes RD, et al. Dermal

injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel

lymph node biopsy: Results of a multi-institutional study. Ann Surg 233:676-687, 2001.

16. Martin RCG, Fong Y, Dematteo RP, Blumgart LH, Jarnagin WR. Peritoneal washings are

not predictive of advanced stage in hilar cholangiocarcinoma. J Am Coll Surg 193:620-625,

2001.

17. Martin RCG, Fey J, Borgen PI, Cody HS. Highest isotope count does not predict sentinel

node positivity in all breast cancer patients. Ann Surg Oncol 8:592-597, 2001.

18. Martin RCG, Jarnagin WR. Randomized Clinical Trials in Hepatocellular Carcinoma and

Biliary Cancer. Surg Oncol Clin North Am, Jan, 11:193-205, 2002.

19. Martin RCG, Klimstra D, Brennan MF, Conlon KC. Solid-pseudo papillary tumors of the

pancreas: A surgical enigma. Ann Surg Oncol 9:35-40, 2002.

20. Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ, McMasters KM. Cost

comparison of endoscopic stenting versus surgical treatment for unresectable

cholangiocarcinoma. Surg Endosc 16:667-670, 2002.

21. Martin RCG, Spain DA, Richardson JD. Do facial fractures protect the brain or are they a

marker for severe head injury? Am Surg 68:478-481, 2002.

22. Martin RCG, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally

advanced gastric cancer: Is it worth the risk of multi-organ resection? J Am Coll Surg,

194(5), 568-577, 2002.

23. Martin RCG, Brennan MF, Jaques DP. The quality of complication reporting in the surgical

literature. Ann Surg 235:803-813, 2002.

24. McMasters KM, Chao C, Wong SL, Martin RCG, Edwards MJ. Sentinel lymph node

biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95:15-20, 2002.

25. Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RCG,

McMasters KM. C-terminal deletion mutant p21 (WAF1/CIP1) enhances E2F-1-mediated

apoptosis in colon adenocarcinoma cells. Cancer Gene Ther 9:453-463, 2002.

26. Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Extended local resection for advanced

gastric cancer: Increased survival vs increased morbidity? Ann Surg 236:159-165, 2002.

27. Martin RCG, Klimstra D, Jarnagin WR, Blumgart LH. Hepatic intraductal oncocytic


24

papillary neoplasm. Cancer 95: 2180-2187, 2002.

28. Martin RCG, Jarnagin WR. Peripheral/Intrahepatic Cholangiocarcinoma: Current

Management. Minerva Chirurgica 58, 469-478, 2003.

29. Martin RCG, Antonescu C, Brennan MF. Adult soft tissue Ewing sarcoma and primitive

neuroectodermal tumors: Is age an adverse predictor of survival? Arch Surg 138: 281-285,

2003.

30. Martin RCG, Jarnagin W, Fong Y, Blumgart L, DeMatteo RP.The Use of Fresh Frozen

Plasma After Major Hepatic Resection For Colorectal Metastasis, Is there a standard for

transfusion? J Am Coll Surg, 196, 402-409, 2003.

31. Martin RCG, Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart

LH. Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? J Am Coll

Surg, 197, 233-242, 2003.

32. Martin RC, Polk HC, Jr., Jaques DP. Does additional surgical training increase participation

in randomized controlled trials? Am J Surg 2003; 185:239-243.

33. Chao C, Abel T, Martin RCG, McMasters KM. Intraoperative Frozen Section of Sentinel

Nodes: A Formal Decision Analysis. Am Surg, 2004;70(3):215-220.

34. D'Angelica M, Martin RCG, Jarnagin WR, Fong Y, DeMatteo RP, Blumgart LH. Major

hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am

Coll Surg 2004;198(4):570-576.

35. Palmer L, Martin RCG, Hein DW. Chemopreventive drug treatment in subjects with

genetic predisposition to cancer: prescriber liability and health care disparities.

Pharmacogenetics. 2004; 5(3):319-329.

36. Chagpar A, Pilavas J, Chao C, Martin RCG, McMasters KM. Sentinel lymph node biopsy

for breast cancer: addressing the controversies. Cancer Therapy 2003, 1:223-232.

37. Chagpar A, Martin RCG, Chao C, Wong, SL, Edwards MJ, Tuttle T, McMasters KM.

Validation of subareolar and periareolar injection techniques for breast sentinel lymph node

biopsy. Arch Surg 2004; 139(6):614-618.

38. Chao C, Martin RCG, Ross MI, Reintgen DS, Edwards MJ, McMasters KM. Correlation

Between Prognostic Factors and Increasing Age in Melanoma. Ann Surg Onc 2004, 11(3),

259-264.


25

39. Chagpar A, Martin RCG, Hagendoorn LJ, Chao C, McMasters KM. Lumpectomy margins

are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg

188(4), 399-402, 2004.

40. D'Angelica M, Martin RC, Jarnagin WR et al. Major hepatectomy with simultaneous

pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg 2004; 198:570-576.

41. Hughes KH, Kelty S, Martin RCG. Hepatoid Carcinoma of the Pancreas. American Surgeon

70, 130-133, 2004.

42. Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W,

Rothman N, Hein DW. Method for Determination of (-102C>T) Single Nucleotide

Polymorphism in the Human Manganese Superoxide Dismutase Promoter. BMC Genetics

5:33, 2004.

43. Edwards MJ, Broadwater R, Tafra L, Jarowenki D, Mabry C, Beitsch P, Whitworth P,

Martin RCG, Oetting L. Progressive adoption of cryoablation therapy for breast

fibroadenoma in community practice. Am J Surg 188, 221-224, 2004.

44. Martin RCG. Intraoperative Magnetic Resonance Imaging Ablation of Hepatic Tumors: A

Surgeon’s Perspective. Am J Surg 189, 388-394, 2005.

45. Martin RCG, Edwards MJ, McMasters KM. Morbidity of Adjuvant Hepatic Arterial

Infusion Pump Chemotherapy in the Management of Colorectal Cancer Metastatic to the

Liver. Am J Surg 188(6), 714-721, 2004

46. Sholar A, Martin RCG, McMasters KM. Popliteal Lymph Node Dissection. Ann Surg Onc

12(2), 189-193,2005.

47. Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W,

Rothman N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102)

Genotypes and Risk of Gastric Cancer. J of Surg Res 124, 92-97, 2005.

48. Martin RCG, D’Angelica M, Blumgart LH. Papillary Low Grade Neuroendocrine Tumor of

the Pancreas with Pancreatic Duct Dilation. Archives of Surgery 140(3), 311-312, 2005.

49. Li Yan, Wo J, Su R, Ray MB, Jones W, Martin RCG. Esophageal Injury with a Novel

External Esophageal Perfusion. J Surg Res 129 (1), 107-113, 2005.

50. Martin RCG, Chagpar A, Scoggins CS, Edwards MJ, Hagendoorn L, Stromberg AJ,

McMasters KM. Clinicopathologic Factors Associated With False Negative Sentinel Lymph

Node Biopsy in Breast Cancer. Ann Surg 241(6), 1005-10012, 2005.


26

51. Martin RCG, Kehdy FJ, Allen JW. Formal Training in Advanced Surgical Technologies

Enhances the Surgical Residency. Am J Surg 190(2), 244-248, 2005. \

52. Chagpar AB, Martin RCG, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, McGlothin

TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM. Factors Predicting Failure to Identify a

Sentinel Lymph Node in Breast Cancer. Surgery 138, 56-63, 2005.

53. Scoggins CR, Chagpar AB, Martin RCG, McMasters KM. Should sentinel lymph-node

biopsy be used for staging melanoma and breast cancers? Nature Clinical Practice Oncology

2(9), 448-455, 2005.

54. Conn CA, McMasters KM, Edwards MJ, Martin RCG. Acceptance of Sentinel Lymph

Node Biopsy of the Breast by All General Surgeons in Kentucky. The Breast Journal 11(4),

231-235, 2005.

55. Herrman B, Li Y, Ray M, Wo J, Martin RCG. Association of Manganese Superoxide

Dismutase Expression with Progression of Carcinogenesis in Barrett’s Esophagus. Archives

of Surgery 140(12), 1204-1209, 2005.

56. Martin RCG, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters

KMM. Is Incisional Biopsy of Melanoma Harmful? Am J Surg 190(6), 913-917, 2005.

57. Hutchinson JR, Chagpar AB, Scoggins CR, Martin RCG, McMaster KM. Surgeon and

community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg 2005;

190:903-906.

58. Martin RCG, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of

Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Ann Surg

Onc 12 (12) 1017-1024, 2005.

59. Martin RCG, Scoggins, CR, McMasters KMM. A Phase II Study of Radiofrequency

Ablation of Unresectable Metastatic Colorectal Cancer with Hepatic Arterial Infusion Pump

Chemotherapy. J Surg Onc 2006; 93(5):387-393.

60. Martin RCG, Augenstein VA, Scoggins CR, McMasters, KM. The Quality of Survival

Reporting in Chemotherapy and Surgery Trials in Metastatic Colorectal Cancer. Cancer 106

(6) 1389-1394, 2006.

61. Chagpar AB, Scoggins CR, Sahoo S, Martin RCG, McMasters KM. Biopsy type does not

influence sentinel lymph node status. Am J Surg 2005; 190:551-556.


27

62. Chagpar AB, Kehdy F, Scoggins CR, Martin RCG, McMasters KM. Effect of

lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast

cancer. Am J Surg 2005; 190:557-562.

63. Li Y, Ray M, Koopman J, Wo JM, Martin RC Cycloxygenase -2 and Epithelial Growth

Factor Receptor up-Regulation during Progression of Barrett's Esophagus to

Adenocarcinoma. World J Gastroenterol, 12(6) 928-934, 2006.

64. Martin RCG, Studts JL, McGuffin SA, Roetzer LM, Abell TA, McMasters KM. Method of

Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-making in

Metastatic Colorectal Cancer. Ann Surg Onc 13(1), 86-95, 2006.

65. Chagpar AB, Studts JL, Scoggins CR, Martin RCG, Carlson DJ, Laidley AL, El-Eid SE,

McGlothin TQ, Noyes RD, McMasters KM. Factors associated with surgical options for

breast carcinoma. Cancer 2006; 106:1462-1466.

66. Li Y, Ellis SE, Ray M, Wo J, Martin RC. A Novel External Esophageal Perfusion Model for

Reflux Esophageal Injury. Digestive Diseases and Sciences, 51(3), 527-532, 2006.

67. Chagpar AB, Scoggins CR, Martin RC, Cook EF, McCurry T, Mizaguchi N, Paris KJ,

Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters, KM. Predicting patients at

low probability of requiring post-mastectomy radiation therapy”. Ann of Surg Onc,

2006:14:670-677.

68. Martin RCG, Husheck Steven, Scoggins CR, McMasters KM. Intraoperative Magnetic

Resonance Imaging Ablation of Hepatic Tumors. Surgical Endoscopy 2006; 20(10): 1536-

1542.

69. Martin RCG. Adjuvant Treatment of Stage II Colon Cancer: Is there a true no

chemotherapy group? Editorial Ann Surg Onc 13(6), 766-767, 2006.

70. D'Angelica M, Maddineni S, Fong Y, Martin RCG, Cohen MS, Ben-Porat L, Gonen M,

DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal abdominal incision for partial

hepatectomy: increased late complications with Mercedes-type incisions compared to

extended right subcostal incisions. World J Surg 2006; 30:410-418.

71. Martin RCG. Hepatic Tumor Ablation: Cryo versus Radiofrequency, which is better?

Editorial Am Surg, 72(5) 391-392, 2006.

72. Lewis A, Martin RCG. The Treatment of Hepatic Metastases in Colorectal Carcinoma.

American Surgeon 2006; 72(6): 466-473.


28

73. Li Y, Wo J, Su R, Ray M, Martin RCG. Morphological Transformation in Esophageal

Submucosa by Bone Marrow Cells Esophageal Implantation under External Esophageal

Perfusion. Stem Cells and Development, Oct, 15 (5):697-705 2006.

74. Eid S, Stromberg AJ, Ames S, Ellis S, McMasters KM, Martin RCG. Assessment of

symptom experience in patients undergoing hepatic resection or ablation. Cancer, 107(11),

2715-2720, 2006.

75. Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin

RCG, Abrecht J, MaMasters KM Prospective multi-institutional study of reverse

transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol

2006; 24:2849-2857.

76. Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin

RCG, Abrecht J, McMasters KM Gender-related differences in outcome for melanoma

patients. Ann Surg 2006; 243:693-700.

77. Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Prediction of sentinel lymph node-

only disease in women with invasive breast cancer. Am J Surg 2006; 192:882-887.

78. Martin RCG, Ahn J, Nowell S, Hein DW, Doll M, Martini B, Ambrosone CB. Association

between Manganese Superoxide Dismutase Promoter Gene Polymorphism and Breast Cancer

Survival. Breast Cancer Research; 8(4), R45- 2006.

79. Chagpar AB, McMasters KM, Martin RC, Scoggins CR. Determinants of early distant

metastatic disease in elderly patients with breast cancer. Am J Surg 2006; 192:317-321.

80. Wells G, Martin RC, McMasters KM, Scoggins CR. Soft tissue sarcoma of the extremity

and trunk: issues for the general surgeon. Am Surg 2006; 72:665-671.

81. Martin RCG. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in

the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus

Statement. Ann Surg Onc 14 (1) 128-133, 2007.

82. Martin RC, Eid S, Scoggins CR. Health-related quality of life: return to baseline after major

and minor liver resection. Surgery 2007; 142:676-684.

83. Li Y., Wo J., Su R, Ray M, Martin RCG. Loss of Manganese Superoxide Dismutase

Expression and Activity in Rat Esophagus with External Esophageal Perfusion. Surgery

141(3) 359-367, 2007.

84. Li Y., Wo J., Su R, Ray M, Martin RCG. Alterations in Manganese Superoxide Dismutase


29

expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann

Surg Onc 14(7) 2045-2055, 2007.

85. Martin RCG, Scoggins CR, McMasters KM. Microwave Hepatic Ablation: Safety and

Efficacy. J Surg Oncol 2007; 96:481-486.

86. Martin RCG, Loehle J, Scoggins CR, McMasters KM. Kentucky Hepatoma:

epidemiological variant or same problem different region? Arch Surg 142(5), 431-436 2007.

87. Woodall CE, Scoggins CR, Loehle J, Ravindra KV, McMasters KM, Martin RCG. Hepatic

Imaging Characteristics Predict Overall Survival in Hepatocellular Carcinoma. Ann Surg

Onc 2007; 14(10):2824-2830.

88. Iannitti D., Martin RCG, Simon C, Newcomb W, McMasters KM, Dupuy, D. Hepatic

Tumor Ablation with Clustered Microwave Antennae: The US Phase II Trial. HPB 9(2); 120-

124, 2007.

89. Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC, Noyes RD,

Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.

Factors associated with improved survival among young adult melanoma patients despite a

greater incidence of sentinel lymph node metastasis. J Surg Res 2007 Nov;143(1):164-168.

90. Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Predicting patients at low

probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2007; 14:670-

677.

91. Weber R, Jabboru N, Martin RCG. Anemia and Transfusions in Patients Undergoing

Surgery for Cancer. Ann Surg Onc 2008; 15(1):34-45.

92. Chagpar AB, Scoggins CR, Martin RC, Carlson DJ, Laidlely AL, Eid SE, McGlothin TQ,

McMasters KM. Are 3 sentinel nodes sufficient? Arch Surg 2007 May;142(5):456-9;

discussion 459-60.

93. Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RCG,

Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN,

Abdalla EK, Curley SA, Choti MA, Elias D. Liver-Directed Surgery for Metastatic

Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis. Ann Surg Onc

June 2007; 14(10):2807-2816.

94. Helm CW, Toler CR, Martin RCG, Gordinier ME, Parker LP, Metzinger DS, Edwards RP.

Cytoreduction and Intraperitoneal Heated Chemotherapy (IPHC) for the Treatment of

Endometrial Carcinoma Recurrent Within the Peritoneal Cavity. Int J. Gynecol Cancer 2007;


30

17(1):204-209.

95. Helm CW, Randall-Whitis L, Martin RCG, Metzinger D, Gordinier M, Parker L, Edwards

R. Hyperthermic Intraperitoneal Chemotherapy In Conjunction With Surgery For The

Treatment Of Recurrent Ovarian Carcinoma. Gynecologic Oncology 2007; 105(1):90-96.

96. Li Y, Martin RCG. Reflux injury of esophageal mucosa: experimental studies in animal

models of esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Dis of

Esophagus 2007; 20(5):372-378

97. Martin RCG Invited commentary for Lancet Oncology 2007 of manuscript: Camacho et al

The Lancet Oncology: http://oncology.thelancet.com

98. Martin RCG, Liu Q, Wo JM, Ray MB, Li Y. Chemoprevention of Carcinogenic Progression

to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation.

Clinical Cancer Research 2007;13(17):5176-5182.

99. Chagpar AB, Scoggins CR, Martin RC, Sahoo S, Carlson DJ, Laidley AL, El-Eid SE,

McMasters KM. Factors determining adequacy of axillary node dissection in breast cancer

patients. Breast J 2007; 13:233-237.

100. Chagpar AB, McMasters KM, Saul J, Nurko J, Martin RC, Scoggins CR, Edwards MJ. Body

mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg. 2007

Jun;73(6):555-60.

101. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Hepatic Malignant

Epithelioid Hemangioendothelioma: A case report and review of the literature. Am Surg

2008; 74(1):64-68.

102. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Adequate

Lymphadenectomy Results in Accurate Nodal Staging without an Increase in Morbidity in

Patients with Gastric Adenocarcinoma. Am J Surg 2008; 196(3) 413-17.

103. Chagpar AB, McMasters KM, Scoggins CR, Martin RC, Thoene C, Edwards MJ. The use

of radiation therapy after breast-conserving surgery in hormonally treated breast cancer

patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg

2008 June; 195(6):793-8.

104. Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist

MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR. Effect of Multiple-Nodal Basin

Drainage on Cutaneous Melanoma. Arch Surg 2008 July;143(7):632-7.


31

105. Landry CS, Scoggins CR, McMasters KM, Martin RCG. Management of Hepatic

Metastasis of Gastrointestinal Carcinoid Tumors. J Surg Oncol 2008; 97(3): 253-258.

106. Li Y, Woodall CE, Wo JM, Zheng H, Ng CK, Ray MB, Martin RCG. The use of dynamic

positron emission tomography imaging for the evaluation of the carcinogenic progression of

intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest 2008 26(3): 278-285.

107. Landry CS, McMasters KM, Scoggins CR, Martin RCG. Proposed Staging System for

Gastrointestinal Carcinoid Tumors. Am Surg 2008 74(5): 418-422.

108. Martin RCG, Barker DF, Doll MA, Pine S, Mechanic L, Bowman ED, Harris CC, Hein

DW. Manganese Superoxide Dismutase Gene Coding Region Polymorphisms Lack Clinical

Incidence in General Population. DNA and Cell Biol. 2008 27(6): 321-323.

109. Landry CS, McMasters KM, Scoggins CR, Woodall CE, Martin RCG. Analysis of 900

Appendiceal Carcinoid Tumors with a Proposal for a Staging System. Arch Surg 2008

143(7): 664-670. G19

110. Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents

in Esophageal Strictures: Less Cost and More Efficiency. Ann Thor Surg 2008, 86(2) 436-

440.

111. Woodall CE, Scoggins CR, Martin RCG. Yttrium-90 use in unresectable primary and

metastatic liver tumors. US Gastroenterology Review, June 2008.

112. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt CM, Merchant N, Parikh A, Martin

RCG; Scoggins C, Ahmad S, Kim HJ, Park J, Johnston F, Strouch M, Menze A, Rymer J;

McClaine R, Strasberg S, Talamonti M, Staley C, McMasters K, Lowy A, Byrd-Sellers J,

Wood W, Hawkins W. Left-sided pancreatectomy: a multicenter analysis of open and

laparoscopic approaches. Annals of Surgery 2008; 248(3):438-446.

113. Deneve J, Pawlik T, Cunningham S, Clary B, Reddy S, Scoggins C, Martin RCG, D'Angelica

M, Staley C, Choti M, Jarnagin, W, Schulick R, Kooby DA. Liver cell adenoma: a

multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2008.

114. Landry CS, Brock, G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging

System for Small Bowel Carcinoid Tumors Based on an analysis of 6,380 patients. Am J

Surg 196(6) 896-903, 2008.

115. Landry CS, McMasters KM, Scoggins CR, Martin RCG A proposed Staging System for

Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients. Ann Surg Onc 16(1), 51-

60, 2009.


32

116. Landry CS, Brock G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging

System for Rectal Carcinoid Tumors based on an Analysis of 4701 patients. Surgery 144(3)

460-466, 2008.

117. Reuter NP, MacGregor JM, Woodall CE, Sticca RP, Helm CW, Scoggins CR, McMasters

KM, Martin RCG. Preoperative performance status predicts outcomes following

hyperthermic intraperitoneal chemotherapy. Am J Surg 2008 December Vol 196(6): 909-14.

118. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RCG. Proposed Staging

System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients. J Am Coll

Surg. 207(6) Dec 2008:874-881.

119. Woodall CE, Duvall R, Scoggins CR, McMasters KM, Martin RCG. Esophageal carcinoma

histology affects peri-operative morbidity following open esophagogastrectomy. J Onc 2008:

1-7

120. Martin RC, Barker DF, Doll MA, Oine SR, Mechanic L, Bowman ED, Haris CC, Hein DW.

Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence

in general population. DNA Cell Biol 2008; 27(6):321-323.

121. Martin RCG, Scoggins CR, Egnatashvili V, Staley C, McMasters KM, Kooby DA. Arterial

and Venous Resection for Pancreatic Adenocarcinoma: Operative and Long-term Outcomes.

Arch Surg 2009; 2:154-159.

122. Martin RCG, Li Y, Liu Q, Jensen NS, Barker DF, Doll MA, Hein DW. Manganese

Superoxide Dismutase V16A Single Nucleotide Polymorphism in the Mitochondrial

Targeting Sequence is Associated with Reduced Enzymatic Activity in Cryopreserved

Human Hepatocytes. DNA Cell Biol, 28(1), 3-7, 2009.

123. Shelgikar CS, Loehle J, Scoggins CR, McMasters KM, Martin RCG. Empiric Antibiotics

for Transarterial Embolization in Hepatocellular Carcinoma: Indicated? J Surg Res 151(1);

121-124: 2009

124. Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents

in Esophageal Cancer Care: Optimal Pre-, Peri-, and Post-operative Care. Surgical

Endoscopy 2009, 23 (3):615-620.

125. Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Radiofrequency

ablation versus resection for hepatic colorectal metastasis therapeutically equivalent? J GI

Surg 2009 Mar: 13(3): 486-91.


33

126. Merchant NB, Rymer J, Koehler EA, Ayers GD, Castellanos J, Kooby DA, Weber SH, Cho

CS, Schmidt CM, Nakeeb A, Matos JM, Scoggins CR, Martin RC, Kim HJ, Ahmad SA,

Chu CK, McCaine R. Bednarski BK, Staley CA, Sharp K, Parikh AA. Adjuvant

Chemoradiation Therapy for Pancreatic Adenocarcinoma: Who Really Benefits? Surg 2009

May; 208(5):829-38.

127. Weber SM, Cho CS, Merchant N, Pinchot S. Rettammel R, Nakeeb A, Bentrem D, Parikh A,

Mazo AE, Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins W, Max

Schmidt C, Kooby DA. Laparoscopic left pancreatectomy: complication risk score

correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009

Oct;16(10):2825-33.

128. Byam J, Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Should

hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver

resection/ablation? Ann Surg Oncol 2009 Nov 3:7:80

129. Li Y, Wo J, Liu Q, Li X, Martin RCG. Chemoprotective Effects of Curcuma Aromatica on

Esophageal Carcinogenesis. Ann Surg Onc 2009; 2:515-523.

130. Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM,

Martin RCG. Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of

Hepatic Resection for Colorectal Cancer Metastases. Ann Surg Onc 16(1), 35-41, 2009

131. Woodall CE, Scoggins CR, Ravindra K, Ellis SF, Tatum CM, Hahl MJ, Hiken JN, Jones BC,

McMasters KM, Martin RCG. Is Selective Internal Radioembolization Safe and Effective

for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis? J Am Coll

Surg 2009 Mar; 208(3): 375-382

132. Martin RCG, Augenstein V, Reuter NR, Scoggins CR, McMasters KM. Simultaneous vs.

Staged Resection for Synchronous Colorectal Cancer Liver Metastases. J Am Coll Surg 2009

May; 208(5):842-850

133. Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. Nutritional Support with

Endoluminal Stenting during Neoadjuvant Therapy for Esophageal Malignancy. Ann Surg

Oncol 2009; 16:31661-3168.

134. Woodall CW, Li Y, Liu Q, Reuter N, Martin RCG. Chemoprevention of metaplasia

initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol

supplementation. Anticancer Drugs 20 (6): 437-443 2009.

135. Woodall CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RCG. An

Evaluation of 2,537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging


34

System. Arch Surg 144(7): 670-678, 2009

136. Woodall CE, Martin RC, Stromberg AJ, Ginter B, Burton A, Ross MI, Edwards MJ,

McMasters KM, Scoggins CR. Do melanoma patients from southern climates have a worse

outcome than those form northern climates? Am Surg 2009 Aug; 75(8):687-92; discussion

692.

137. Reuter NP, Martin RCG. Microwave energy as a pre-coagulative device to assist in hepatic

resection. Ann Surg Onc 16: 3057-3063, 2009

138. Bower M, Martin RCG. Nutritional Management during Neoadjuvant Therapy for

Esophageal Cancer. J Surg Onc 2009 July Vol 100(1): 82-87

139. Martin RCG, Robbins K, Tomalty D, O’Hara R, Bosnjakovik Padr R, P, Derner M, Rocek

M, Slauf F, Scupchenko A, and Tatum C. Transarterial chemoembolization (TACE) using

irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients

with colorectal cancer: An Interim Report. World J of Surg Onc 2009, 7:80:1-12.

140. Jones, WF, Martin RCG. Confronting the barriers to colorectal cancer screening and

treatment. J KY Med Assoc, 107(3): 86-87, 2009

141. Martin RCG, Joshi J, Robbins K, Tomalty D, O’Hara R. Tatum C. Transarterial

Chemoembolization of Metastatic Colorectal Carcinoma with Drug Eluting Beads: Multi-

Institutional Study. J of Oncology 12(5), 539-545, 2009

142. Schiffman SC, Woodall CE, Kooby DA, Martin RC, Staley CA, Egnatashvili V, McMasters

KM, Scoggins CR. Factors associated with recurrence following hepatectomy for large

hepatocellular carcinoma: A multicenter analysis. J Surg Oncol 2009; 101(2);105-11.

143. Martin RC, Scoggins CR, McMasters KM. Safety and Efficacy of microwave ablation of

hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010

Jan;17(1):171-8

144. Li Y, Reuter NP, Li X, Liu Q, Zhang J, Martin RCG. Colocalization of MnSOD expression

in response to oxidative stress. Mol Carcinog 2010 Jan;49(1):44-53

145. Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE,

Sussman JJ, Beitsch PD, McMasters KM. Factors Associated with False-Negative Sentinel

Lymph Node Biopsy in Melanoma Patients. Ann Surg Oncol 2010 17:709-717.

146. Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters KM, Martin RCG. Safety

of Hepatic Resection in metastatic disease to the liver after Yttrium-90 therapy. J Surg Res


35

Available online 12 June 2009.

147. Martin RCG, Li Y, Liu Q, Barker DF, Doll MA, Hein DW. MnSOD genotype and the

expression effects on Lung Cancer Initiation and Biology. Cancer Investigation 1-7, 2009

ISSN: 0735-7907 print / 1532-4192 online

148. Carter S, Martin RCG. Drug Eluting Bead Therapy in Primary and Metastatic Disease to

the Liver. HPB 11(7), 541-550, 2009

149. Benns M, Woodall C, Scoggins CR, McMasters KM, Martin RCG. The Impact of Obesity

on Outcomes Following Pancreatectomy for Malignancy. Ann Surg Onc 16((), 2565-2569,

2009.

150. Bower MR, Metzger T, Robbins K, Tomalty D, Andrasina T, Tatum C, Scoggins CR,

McMasters KM, Martin RCG. Surgical Downstaging and Neo-adjuvant therapy in

metastatic colorectal carcinoma with irinotecan drug eluting beads: a multi-institutional

study. HPB 12(1); 31-36, 2010.

151. Martin RCG, McMasters KM, Scoggins CR. Laparoscopic Hepatic Lobectomy: Advantages

Of A Minimally Invasive Approach. JACS 210(5) 627-631, 2010.

152. Bower MR, Aiyer HA, Martin RCG. Chemoprotective Effects of Curcumin in Esophageal

Epithelial Cells Exposed to Bile Acids. WJ Gastroenterology 16(33): 4151-4158, 2010.

153. V. J. Picozzi; R. A. Abrams; P. A. Decker; W. Traverso; E. M. O'Reilly; E. Greeno; R.C.

Martin; L. S. Wilfong; M. L. Rothenberg; M. C. Posner; P. W. T. Pisters; for the American

College of Surgeons Oncology Group. Multicenter phase II trial of adjuvant therapy for

resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based

chemoradiation: ACOSOG Trial Z05031. Annals of Oncology 2010; doi: 10.1093/annonc

154. Brown R, Bower M, Martin RCG. Hepatic Resection for Colorectal Liver Metastases

Surgical Clinics of North America (SCNA) Liver Surgery, 90(4): 839-852, 2010.

155. Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. The role of esophageal stents in

the nutritional support of patients with esophageal malignancy. Nutrition in Clinical Practice

June 2010 Vol 25(3); 244-249

156. Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM,

Stromberg AJ, McMasters KM, Scoggins CRl. Should all patients with melanoma between 1

and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 Mar 15,

116(6) pp 1535-44.


36

157. Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR, McMasters

KM, Martin RCG. Is prior cholecystectomy associated with decreased survival in patients

with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg

Available online Sept 28

158. Augenstein VA, Reuter NP, Bower MR, McMasters KM, Scoggins CR, Martin RCG.

Routine intra-operative biliary cultures during pancreaticoduodenectomy: A guide to avoid

postoperative complications. J Surg Onc 2010 Oct 1; 102(5); 478-81.

159. Martin RCG, Howard J, Tomalty D, Robbins K, Padr R, Bosnjakovic PM, Tatum C.

Toxicity of Irinotecan Eluting Beads in the treatment of Hepatic Malignancies: Results of

Multi-Institutional Registry. CVIR 2010; 33(5) 960-66.

160. Bowling, J. T.; Reuter, N. P.; Martin, R. C.G.; McMasters, K. M.; Tatum, C.; Scoggins, C.

R. Prior Biliary Tree Instrumentation Does Not Preclude Hepatic Arterial Therapy for

Malignancy. Am. Surg 2010; 76, 618-621.

161. Brown R, Hagendoorn L, Stromberg AJ, Scoggins CR, McMasters KM, Martin RCG.

Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest Radiography.

Surgery 2010 Vol 148(4) 711-717.

162. Schiffman SC, Li Y, Dryden GW, Li X, Martin RCG. Image analysis by mini-endoscopy in

rats after esophagoduodenal anastomosis. Surg Endo 24 (11) 2835-2841, 2010.


37

163. Schiffman SC, Li Y, Li X, Aiyer HA, Martin RCG. The Resistance if Esophageal

Cancer Cells to Bile Salt Insult Is Associated with Manganese Superoxide Dismutase. J

Surg Res 2010. Vol 158(2) Feb 2010, page 2.

164. Aiyer HS, Li Y, Losso JN, Gao C, Schiffman SC, Slone SP, and Martin RC: Effect of

freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.

Nutr Cancer 2011, 63:1256-1262

165. Aiyer HS, Li Y, Harper N, Myers SR, and Martin RC: Molecular changes in the

esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of

bile-acid reflux. Inhal Toxicol 2011, 23:304-311

166. Aiyer HS, Li Y, Liu QH, Reuter N, and Martin RC: Dietary freeze-dried black

raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.

Nutrition 2011, 27:182-187.

167. Aiyer, HS, Li Y, and Martin RC: Diet composition affects surgery-associated weight

loss in rats with a compromised alimentary tract. J Surg Res 2011, 168:42-48

168. Bower M, Sherwood L, Li Y, and Martin R: Irreversible electroporation of the pancreas:

definitive local therapy without systemic effects. J Surg Oncol 2011, 104:22-28

169. Bower M, Ellis SF, Scoggins CR, McMasters KM, and Martin RC: Phase II comparison

study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol

2011, 18:166-173

170. Brown RE, St Hill CR, Greene QJ, Farmer RW, Reuter NP, Callendar GG, Martin RC,

McMasters KM, and Scoggins CR: Impact of histology on survival in retroperitoneal

sarcomas. Am J Surg 2011, 202:748-752

171. Brown RE, Abbas AE, Ellis S, Williams S, Scoggins CR, McMasters KM, and Martin RC:

A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for

esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011, 212:582-

588

172. Brown RE, Gibler KM, Metzger T, Trofimov I, Krebs H, Romero FD, Scoggins CR,

McMasters KM, and Martin RC: Imaged guided transarterial chemoembolization with drug-

eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma:

early outcomes from a multi-institutional registry. Am Surg 2011, 77:93-98

173. Brown RE, Martin RC, and Scoggins CR: Ablative therapies for colorectal liver

metastases. Surg Oncol Clin N Am 2011, 20:259-71, vii


38

174. Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ, Tatum C,

and Martin RC: Hepatectomy after hepatic arterial therapy with either yttrium-90 or

drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 2011, 13:91-95

175. Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC,

McMasters KM, Scoggins CR, and Callender GG: Regression does not predict nodal

metastasis or survival in patients with cutaneous melanoma. Am Surg 2011, 77:1009-

1013

176. Burton AL, Roach BA, Mays MP, Chen AF, Ginter BA, Vierling AM, Scoggins CR,

Martin RC, Stromberg AJ, Hagendoorn L, and McMasters KM: Prognostic significance

of tumor infiltrating lymphocytes in melanoma. Am Surg 2011, 77:188-192

177. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ,

Hagendoorn L, Martin RC, and McMasters KM: Prognostic implications of anatomic

location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011, 202:659-

664

178. Cannon RM, Martin RC, Callender GG, McMasters KM, and Scoggins CR: Safety and

efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011,

104:804-808

179. Chagpar RB, Martin RC, Ahmad SA, Kim HJ, Rupp C, Weber S, Ebelhar A, Gilbert J,

Brinkman A, Winslow E, Cho CS, Kooby D, Chu CK, Staley CA, McMasters KM, and

Scoggins CR: Medically managed hypercholesterolemia and insulin-dependent diabetes

mellitus preoperatively predicts poor survival after surgery for pancreatic cancer. J

Gastrointest Surg 2011, 15:551-557.

180. Cho CS, Kooby DA, Schmidt CM, Nakeeb A, Bentrem DJ, Merchant NB, Parikh AA,

Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins WG, and Weber

SM: Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the

safer technique? Ann Surg 2011, 253:975-980

181. Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown

RE, St Hill CR, Hagendoorn L, Martin RC, Stromberg AJ, and Scoggins CR:

Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 2011, 77:992-

997

182. Farmer RW, , Kralj I, Valdata A, Urbano J, Enguix DP, Monaco RG, Scoggins CR,

McMasters KM, Rustein L, and Martin RC: Hepatic arterial therapy as a bridge to

ablation or transplant in the treatment of hepatocellular carcinoma. Am Surg 2011,


39

77:868-873

183. Li Y, Martin RC: Herbal medicine and hepatocellular carcinoma: applications and

challenges. Evid Based Complement Alternat Med 2011:541209

184. Li Y, Reuter N, Li XS, Martin RCG. Manganese superoxide dismutase

chemoprevention in a murine hepatitis associated injury model. Journal of Cancer

Therapy 2011;2:431-440.

185. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, McMasters

KM, Cho CS, Winslow ER, Wood WC, and Staley CA, III: Importance of low

preoperative platelet counts in selecting patients for resection of hepatocellular

carcinoma: a multi-institutional analysis. J Am Coll Surg 2011, 212:638-648

186. Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, and

McMasters KM: Readmission rates after abdominal surgery: the role of surgeon, primary

caregiver, home health, and subacute rehab. Ann Surg 2011, 254:591-597

187. Martin RC, Rustein L, Perez ED, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj

I, Bosnjakovic P, and Tatum C: Hepatic arterial infusion of doxorubicin-loaded

microsphere for treatment of hepatocellular cancer: a multi-institutional registry. J Am

Coll Surg 2011, 213:493-500

188. Martin RC, Kooby DA, Weber SM, Merchant NB, Parikh AA, Cho CS, Ahmad SA,

Kim HJ, Hawkins W, and Scoggins CR: Analysis of 6,747 pancreatic neuroendocrine

tumors for a proposed staging system. J Gastrointest Surg 2011, 15:175-183 2011 Best J

of GI Surg Paper Award Winner

189. Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M, Padr R, Rocek

M, Scupchenko A, and Tatum C: Hepatic intra-arterial injection of drug-eluting bead,

irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic

chemotherapy: results of multi-institutional study. Ann Surg Oncol 2011, 18:192-198

190. Picozzi VJ Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC,

Wilfong LS, Rothenberg ML, Posner MC, and Pisters PW: Multicenter phase II trial of

adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and

interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol 2011,

22:348-354

191. Ramsey AM and Martin RC: Body mass index and outcomes from pancreatic resection:

a review and meta-analysis. J Gastrointest Surg 2011, 15:1633-1642


40

192. Schiffman SC, Li Y, Xiao D, Li X, Aiyer HS, and Martin RC: The resistance of

esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide

dismutase expression. J Surg Res 2011, 171:623-630

193. Schiffman SC, McMasters KM, Scoggins CR, Martin RC, and Chagpar AB: Lymph

node ratio: a proposed refinement of current axillary staging in breast cancer patients. J

Am Coll Surg 2011, 213:45-52

194. Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR,

McMasters KM, and Martin RC: Is prior cholecystectomy associated with decreased

survival in patients with resectable pancreatic adenocarcinoma following

pancreaticoduodenectomy? Am J Surg 2011, 201:519-524

195. Schiffman SC, Metzger T, Dubel G, Andrasina T, Kralj I, Tatum C, McMasters KM,

Scoggins CR, and Martin RC: Precision hepatic arterial irinotecan therapy in the

treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and

prolonged overall survival. Ann Surg Oncol 2011, 18:431-438

196. Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl M, and Martin

RC: Transarterial chemoembolization and selective internal radiation for the treatment of

patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.

Oncologist 2011, 16:594-601

197. Whitney R, , Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K, and Martin RC:

Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J

Surg Res 2011, 166:236-240

198. Cannon RM, , Legrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho

CS, Brinkman A, Weber S, Winslow ER, Kooby DA, Chu CK, Staley CA, Glenn I,

Hawkins WG, Parikh AA, Merchant NB, McMasters KM, Martin RC, Callender GG,

Scoggins CR. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating

the effect of diabetes status on survival after resection. HPB (Oxford). 2012

Apr;14(4):228-35.

199. Callender GG, Gershenwald JE, Egger ME, Scoggins CR, Martin RC 2nd, Schacherer

CW, Edwards MJ, Urist MM, Ross MI, Stromberg AJ, McMasters KM. A Novel and

Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel

Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model.

J Am Coll Surg. 2012 Feb 16. Vol 214(4):608-17

200. Schiffman SC, Li Y, Martin RC. The Association of Manganese Superoxide Dismutase

Expression in Barrett's Esophageal Progression with MnTBAP and Curcumin Oil


41

Therapy. J Surg Res. 2011 Dec 13Vol 176(2): 535-541

201. Mbah NA, Brown RE, Bower MR, Scoggins CR, McMasters KM, Martin RC.

Differences between bipolar compression and ultrasonic devices for parenchymal

transection during laparoscopic liver resection. HPB (Oxford). 2012 Feb;14(2):126-31

202. Martin RC, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R.

Optimal outcomes for liver-dominant metastatic breast cancer with transarterial

chemoembolization with drug-eluting beads loaded with doxorubicin. Breast Cancer

Res Treat. 2012 Apr;132(2):753-6363

203. Dunki-Jacobs EM, Martin R. Endoscopic Therapy for Barrett's Esophagus: A Review

of Its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Oncol.

2012 Vol 19(5): 1575-92

204. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ,

Hagendoorn L, Martin RC 2nd, McMasters KM. Prognostic implications of

anatomiclocation of primary cutaneous melanoma of 1 mm or thicker. Am J Surg. 2011

Dec;202(6):659-64; discussion 664-5.

205. Harper N, Li Y, Farmer R, Martin RC. Epidermal Growth Factor Expression in

Esophageal Adenocarcinoma: A Clinically Relevant Target? J Gastrointest Surg. 2012

Vol 16:946-955

206. Martin RCG, Geller DA, Espat JN, Kooby DA, Sellars M, Goldstein RG, Imagawa DK,

Ulrich F, Scoggins CR. Safety and Efficacy of Trans Arterial ChemoEmbolization with

Drug-Eluting Beads in Hepatocellular Cancer: An Optimal Therapy.

Hepatogastroenterology 2012; Vol 59(113): 255-260.

207. Li Y, Reuter NP, Liu Q, Li X, Martin RCG. Manganese Superoxide Dismutase

Chemoprevention in a Murine Hepatitis Associated Injury Model. J of Cancer Therapy

2011; Vol 2(3): 431-440

208. Joshi J, Robbins K, Valek V, Andrasina T, Boudny J, Padr R, O’Hara R, Tomalty D,

Martin RCG. Hepatic Arterial Infusion – Doxorubicin Loaded Microsphere for the

Treatment of Metastatic Breast Cancer to the Liver: Results from a Multi-Institutional

Registry. Interven Oncology 2010.

209. Brown RE, Abbas AE, Ellis SF, White S, Scoggins CR, McMasters KM, Martin RCG.

A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for

Esophageal Cancer: Optimal Performance and Surgical Safety. J Am Col Surg 2011; Vol

212(4): 582-88.


42

210. Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl, M, Martin RCG.

Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of

Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost.

The Oncologist 2011; Vol 16(5): 594-601.

211. Martin RCG, Irurzun I, Munchart J, Trofimov I, Scupchenko A, Tatum C, Narayanan G.

Optimal Technique of Doxorubicin Beads in Hepatocellular Cancer: beads size, dose, and

response. Korean J Hepatol 2011. Vol 17; 51-60.

212. Farmer R, , Kralj I, Valdata A, Urbano J, Pérez Enguix D, Monaco R, Scoggins CR,

McMaster KM, Rustein L, Martin RCG. Hepatic Arterial Therapy as a Bridge to

Ablation or Transplant in the Treatment of Hepatocellular Carcinoma. Am Surg 2011;

Vol 77(7): 868-873.

213. Ramsey A, Martin RCG. Body Mass Index and Outcomes Following Pancreatectomy:

A Meta Analysis. J or GI Surg 2011; Vol 15: 1633-1642.

214. Aiyer HS, Li Y, Harper N, Myers SR, Martin RCG. Molecular changes in the

esophageal epithelium after subchronic exposure to cigarette smoke in the presence of

bile-acid reflux. Inhalational Toxicol 2011. Vol 23(5): 304-311.

215. Schiffman S, Reuter NP, McMaster KM, Scoggins CR, Martin RCG. Overall Survival

of Peri-Hilar Cholangiocarcinoma Compared to Primary Endoscopic Therapy. J Surg

Onc 2010; Vol 105(1): 304-11.

216. Martin RCG, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A,

Kralj I, Bosnjakovic P, Tatum C. Hepatic Arterial Infusion of Doxorubicin Loaded

Microsphere for Treatment of Hepatocellular Cancer: a Multi-Institutional Registry.

JACS 2011; Vol 213(4): 493-500.

217. Martin RCG, Brown R, Puffer L, Block S, Scoggins CR, McMaster KM. Readmission

Rates after Abdominal Surgery: The Role of Surgeon, Primary Caregiver, Home Health,

and Sub-acute Rehab. Ann Surg 2011; Vol 254(4): 591-95.

218. Martin RCG, Aiyer HS, Malik D, Li Y. Effect on Pro-inflammatory and Antioxidant

Genes and Bioavailable Distribution of Whole Tumeric vs Curcumin: Similar Root but

Different Effects. Food and Chemical Toxicology 2011; Vol 50(2); 227-31.

219. Dunki-Jacobs E, Martin RCG. Endoscopic Therapy for Barrett’s Esophagus: A Review

of its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Onc

2011; Vol 19(5): 1575-82.


43

220. Cannon RM, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A,

Kralj I, Bosnjakovic P, Tatum C, Martin RCG. Management of Diffuse Hepatocellular

Cancer (≥ 10 Lesions) with Doxorubicin Loaded DC Bead is Safe and Effective

Treatment Option. Onkologie 2012; Vol 35: 184-188.

221. Mbah N, Brown RE, St Hill CR, Bower MR, Ellis SE, Scoggins CR, McMasters KM,

Martin RCG. Impact of Post-Operative Complications on Quality of Life after

Pancreaticoduodenectomy. J of Pancreas 2012: Vol 13(4): 387-393.

222. Fox M, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Lymph Node Ratio is a

Significant Predictor of Disease Specific Mortality in Patients Undergoing

Esophagectomy for Cancer. Am Surg 2012; Vol 78(5): 528-34..

223. Kotoyan R, Lindeman T, Tatum C, Robbins K, Martin RCG. Hepatic Arterial Therapy

with Drug-eluting Beads in the management of Metastatic Pancreatic Carcinoma to the

Liver: a Multi-Institutional Registry. J of Oncology 2012: Article ID 168303: 1-6.

224. Lencioni R, Martin RCG, Geshwind J. Transcather treatment of HCC with DC Bead

Doxorubicin (DEBDOX) Technical Recommendations. CVIR 2012 Vol 35: 980-985

225. Schiffman SC, Li Y, Diao X, Li X, Aiyer HA, Martin RCG. The Association of

Manganese Superoxide Dismutase Expression in Barrett’s Esophageal Progression with

MnTBAP and Curcumin Oil Therapy. J Surg Res; Vol 176(2):535-41.

226. Fouad H, Metzger T, Tatum C, Robbins K, Martin RCG. Hepatic arterial therapy with

drug eluting beads in the management of metastatic bronchogenic carcinoma to the liver:

a multi-institutional registry. J of Oncology 2012; Article ID 292131: 1-6.

227. Martin RCG, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R.

Optimal Outcomes for Liver Dominant Metastatic Breast Cancer with Transarterial

Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin. Br C Res Tre

2012; Vol 132(2): 753-63.

228. Martin RCG, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, Sharma V.

Irinotecan Drug-eluting Bead in the Treatment of Chemo-Naïve Unresectable Colorectal

Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of

Pharmacokinetics and Phase I Trial. J GI Surg 2012; Vol 16(8): 1531-38.

229. Martin RCG, McFarlin K, Ellis S, Velanovich V. Irreversible Electroporation Therapy

in the Management of Locally Advanced Pancreatic Adenocarcinoma. JACS 2012; Vol

215(3): 361-69.


44

230. O’Brien M, Pavlov V, Robbins K, Padr R, Martin RCG. Hepatic Arterial Therapy with

Drug eluting Beads in the management of Metastatic Renal Cell Carcinoma to the Liver:

a Multi-Institutional Registry. J Surg Rad 2012

231. Lee T, Martin RCG. Readmission Rates After Abdominal Surgery: Can They Be

Decreased to a Minimum? Advances in Surgery 2012. Vol 46:155-170

232. Cannon B, Scoggins CR, Callender G, McMasters KM, Martin RCG. Laparoscopic

Versus Open Resection of Hepatic Colorectal Metastases. Surgery 2012. Vol 152:567-

573

233. Fox M, von Berkel V, Bousamra M, Sloan S, Martin RCG. Surgical Management of

Pulmonary Carcinoid Tumors: Sub-lobar Resection versus Lobectomy. Am J Surg

2013.Vol 205(2):300-208

234. Bower M, Scoggins CR, McMasters KM, Martin RCG. Body Mass Index and Liver

Dysfunction Am J Surg 2013.

235. Li Y, Brown R, Li X, Martin RCG. Incomplete Thermal Ablation of Hepatocellular

Carcinoma Leads to Enhanced Cellular Viability and Resistance to Programmed Cell

Death. J Surg Res. Vol. 181(2):250-255

236. Rhodes Brown, Martin RCG. Management of Liver Dominant Metastatic Breast

Cancer: Surgery, Chemotherapy, or Hepatic Arterial Therapy – Benefits and Limitations.

Minerva Chirurgica 2012. Vol 67(4):297-308

237. Cannon RM, Ellis S, Hayes D, Narayanan G, Martin RCG. Safety and Early Efficacy of

Irreversible Electroporation for Hepatic Tumors in Proximity to Vital Structures. J Surg

Onc 2012. Vol 107(5):544-549

238. Martin RCG, R Salem, R Adam, E Dixon. Commentary Local regional surgical and

interventional therapies for advanced colorectal liver metastasis: expert consensus

statement. HPB 2013. Vol 15(2): 131-133.

239. Martin RCG, McFarland K, Ellis S, Velanovich V: Irreversible Electroporation in

Locally Advanced Pancreatic Cancer: Potential Improvement in Overall Survival. Ann

Surg Onc 2013. Vol 20 (S3):443-449.

240. Egger, M, Martin RCG. The Assessment of Chemotherapy Response in Colorectal Liver

Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic

Residual Viable Tumor. JACS 2012 Vol 216(4) :845-56


45

241. Edwards J, Scoggins CR, McMasters KM, Martin RCG. Combined Pancreas and Liver

Therapies: Resection and Ablation In Hepato-Pancreatico-Biliary Malignancies. J Surg

Onc 2012. Vol 107(7) 709-712

242. Miller A, St Hill CR, Ellis SF, Martin RCG. Health-Related Quality of Life Changes

Following Major and Minor Hepatic Resection: The Impact of Complications and Post-

operative Anemia. Am J Surg 2013. Vol 206(4):443-450.

243. Burnett NP, Dunki-Jacobs E, Callender GG, Anderson RJ, Scoggins CR, McMasters

KM, Martin RCG. Evaluation of AFP Staging System for Hepatocellular Carcinoma in

Non-cirrhotic Patients. Am Surgeon 2013. Vol 79 (7):716-22

244. Martin RCG. Irreversible Electroporation: A Novel Option for Treatment of Hepatic

Metastases. Current Colorectal Cancer Reports 2013 Vol 9(2):191-197.

245. Cannon RM, Scoggins CR, Callender G, Quillo A, McMasters KM, Martin RCG. A

Deviation Based Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection.

Ann Surg Onc 2013. Vol 20(9): 2887-2892.

246. Lee T, Martin RCG. Surgical Quality of Care in Esophageal Malignancies. Future

Oncology 2012. Vol 9(4): 575-584.

247. Anderson R, Dunki-Jacobs E, Callender G, Burnett N, Scoggins CR, McMasters KM,

Martin RCG. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical

Efficacy or Limited Benefit? Surgery 2014 154(4):755-760

248. Li Y, Shi W, Zhang J, Zhang X, Martin RCG. Hepatic Protection and Anti-cancer

Activity of Curcuma: A Potential Chemopreventive Strategy against Hepatocellular

Carcinoma. Int J Oncol 44: 505-513, 2014

249. Schiffman SC, Nowacki M, McMasters KM, Scoggins CR, Martin RC. Molecular

factors Associated with recurrence and Survival Following Hepatectomy in Patients with

Intrahepatic Cholangiocarcinoma: A Guide to Adjuvant Clinical Trials. J of Surg Onc

2014 Vol 109(2) Feb 2014:98-103

250. Mbah N, Scoggins CR, McMasters KM, Martin RCG. Impact of Hepatectomy Margin on

Survival following Resection of Colorectal Metastasis: The Role of Adjuvant Therapy and

Its Effects. Eur J Surg Onc Vol 39(12) Dec 2013:1394-1399.

251. Dunki-Jacobs, E, Philips P, Martin RCG. Evaluation of Resistance as a Measure of

Successful Tumor Ablation in Irreversible Electroporation of the Pancreas. JACS Feb


46

2014 Vol 218(2):179-187

252. Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Stroke Volume

Variation in Hepatic Resection: A Replacement for Standard Central Venous Pressure

Monitoring. Ann Surg Onc Feb 2014 Vol 21(2):473-78

253. Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O’Grady E, Riling

WS, Walker D, Martin RCG. Transcatheter Treatment of Colorectal Cancer Liver

Metastases with Irinotecan-Loaded DC Bead (DEBIRI): Technical Recommendations.

JVIR March 2014 Vol 25(3):365-369

254. Martin RCG, Cannon RM, Brown RE, Ellis SF, Williams S, Scoggins CR, Abbas A.

Evaluation of Quality of Life Following Placement of Self-Expanding Plastic Stents as a

Bridge to Surgery in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer.

The Oncologist 2014 Vol 19(3):259-65

255. Anderson R, Dunki-Jacobs E, Burnett N, Scoggins CR, McMasters KM, Martin RCG. A

Cost Analysis of Somatostatin use in the Prevention of Pancreatic Fistula After

Pancreatectomy. W J Surg August 2014. Vol 38(8):2138-2144

256. Martin RCG, Philips P, Hayes D, Bagla S,. Irreversible Electroporation of Unresectable

Soft Tissue Tumors with Vascular Invasion: Effective Palliation. BMC Cancer. 2014,

14:540

257. Martin RCG. Irreversible Electroporation for Locally Advanced Pancreatic Cancer. J GI

Surg 2013. Vol 7(10):1850-1856

258. Philips P, Hayes D, Martin RCG. Irreversible Electroporation Ablation (IRE) of

Unresectable Soft Tissue Tumors: Learning Curve evaluation in the first 150 patients

treated. PLOS One Medicine 2013. Vol 8(11).

259. North AD, Schlegel M, Martin RCG. Gastroesophageal Reflux Disease-Related

Symptom Assessment in Subjects with Malignant Dysphagia receiving Esophageal

Stents. Am Surg December 2014. Vol 80(12):1260-1265

260. Li X, Li Y, States VA, Li S, Zhang X, Martin RCG. The effect of black raspberry

extracts on MnSOD activity in protection against concanavalin A induced liver injury.

Nutrition and Cancer: International Journal 2014. Vol 66(6):930-937

261. North AD, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C,

Rilling WS, TC Gamblin, Martin RCG. Microwave Ablation for Hepatic Malignancies:

A Call for Standard Reporting and Outcomes. Am J Surg 2014. Vol 208(2):284-294


47

262. Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Evaluation of Thermal

Injury to Liver, Pancreas, and Kidney during Irreversible Electroporation in an In-vivo

Porcine Model. Br J Surg 2014. Vol 101(9):1113-1121

263. Philips P, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Caudate Lobe

resections: A single center experience and evaluation of factors predictive of outcomes.

W Journal Surg Onc 2013:11:220

264. Agle S, Philips P, Martin RCG. Environmental Exposures, Tumor Heterogeneity, and

Colorectal Cancer Outcomes. Curr Colorect Reports 2013 Vol 10(2): 189-194

265. Bruenderman E, Martin RCG. High-Risk Population in Sporadic Pancreatic

Adenocarcinoma: Guidelines for Screening. J Surg Res 2014 In Press

266. Wehry J, Cannon B, Scoggins CR, Puffer L, McMasters KM, Martin RCG. Restrictive

Blood Transfusion Protocol in Liver Resections Patients Reduces Blood Transfusions

with No Increase in Patient Morbidity. Am J Surg 2014. In Press

267. Philips P, Dunki-Jacobs E, Agle SC, Scoggins CR, McMasters KM, Martin RCG. The

role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a

selection criterion for surgery. HPB. 2014 Vol 16(12):1051-1055

268. Doughtie CA, Priddy EE, Philips P, Martin RCG, McMasters KM, Scoggins CS.

Preoperative dosing of low-molecular weight heparin in hepatopancreatobiliary surgery.

The Am J of Surg. 2014 Vol 208(6):1009-1015

Accepted for Publication

1. Martin RCG, Schwartz E, Adams J, Farah I, Derhake B. Intra-operative Anesthesia

Management in Patients Undergoing Surgical Irreversible Electroporation of the

Pancreas, Liver, Kidney, and Retroperitoneal Tumors. Anesthesia and Pain, 2014

2. Akinwande OK, Martin RCG. Small (75-150 microns) versus medium sized drug

eluting beads (DEBIRI) for the treatment of colorectal metastases – A Multi-institutional

propensity score matching analysis. CVIR 2014

3. Akinwande OK, Miller AR, Martin RCG. Concominant Capecitabine with Hepatic

Arterial Infusion of Drug Eluting Beads in the management of metastatic colorectal

cancer: A Multi-Institutional prospective study. – Anti Cancer Research 2014


48

4. Bruedermann E, Martin RCG. A Cost Analysis of a Pancreatic Cancer Screening

Protocol in High-Risk Populations. Am J of Surg 2014

5. Kwon D, McFarland K, Velanovic V, Martin RCG. Borderline and Locally Advanced

Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin

Accentuation. Surgery 2014. Vol 156(4):910-922

6. Martin RCG Irreversible Electroporation in Locally Advanced Pancreatic

Adenocarcinoma Body/Neck – Technique Paper. J of Gastrointestinal Oncology 2015

Submitted for Publication

1. Lu Z, Li Y, Takwi A, Conklin D, Martin RCG, Li Y. A MicroRNA-Mediated NF-

kappaB Activation in Pancreatic Cancer Cells. J Nat Ca Institute 2008.

2. St Hill CR, Brown R, Scoggins CR, McMasters KM, Martin RCG. Operative Duration

and the Effects on Perioperative Outcomes after Pancreaticoduodenectomy.

Hepatogastroenterology 2012.

3. Farmer RW, Scoggins CR, McMasters KM, Martin RCG. Factors Predictive of Adverse

Outcomes in Gallbladder Cancer. W J Surg 2012.

4. St Hill CR, Mbah NA, Cannon R, Brown R, Kooby D, Staley C, Cho CS, Weber S,

Winslow S, Scoggins CR, McMasters KM, Martin RCG. Laparoscopic versus Open

Resection for Hepatocellular Carcinoma: Improvement in Outcomes and Similar Cost.

Surgical Endoscopy 2013.

5. Martin RCG. 2013 State of the Art Lecture: Evolving Management in Pancreatic

Cancer: Use of Irreversible Electroporation in Unresectable Pancreatic Cancer.

Hepatobiliary Surgery and Nutrition 2014.

6. Akinwande OK, Ahmad SS, Van Meter T, Schultz B, Martin RCG. Irreversible

Electroporation in Locally Advanced Pancreatic Cancer: CT Findings in “Typical”

Post-IRE Changes vs Local Recurrence”. Acta Radiologica

7. Oliver A, Martin RCG. Evaluating the PK/PD and clinical efficacy of DC Bead - a

doxorubicin- eluting polymer for treating liver cancer. Expert Opinion On Drug

Metabolism and Toxicology 2014

8. Martin RCG, Locatelli E, Li Y, Weizhong Z, Li S, Monaco I, Comes-Franchini M.


49

Gold Nanorods and Curcumin-Loaded Nanomicelles for efficient in vivo Photothermal

Therapy of Barrett’s Esophagus. ACS Nanomedicine 2014.

9. Akinwande OK, Kim D, Edwards J, Brown R, Philips P, Scoggins CR, Martin RCG.

Comparative analysis of transarterial therapy for unresectable hepatocellular carcinoma

with portal vein thrombosis: Radioembolization (90Y) versus doxorubicin drug eluting

beads (DEBDOX). Surgical Oncology

BOOK CHAPTERS

1. Martin RCG, Karpeh M. An Internist’s Illustrated Guide to Gastrointestinal Surgery:

Surgical Management of Gastric Tumors. The Humana Press, INC. Totowa, NJ. 2003.

2. Martin RCG, McMasters KM. Surgical Complications, Risks and Consequences:

Textbook Surgery: Complications, Risks and Consequences 7-Volume Series. Chapter -

Surgery: Complications, Risks and Consequences - Upper Abdominal Surgery (ISBN-13:

978-1447154358) - Springer

3. Martin RCG, Kidd L, Hein DH. Colo-rectal Cancer Susceptibility: The Role of

Polymorphic N-Acetyltransferase Genes (NAT1 and NAT2), Heterocyclic Aromatic

Amines, and Gene-diet Interactions. CRC Press LLC 2005.

4. Scoggins CR, Martin RCG, McMasters KM. Duodenal Cancer. In: Pollock RE, Curley

SA, Ross MI, Perrier ND, editors. Advanced Therapy in Surgical Oncology, 1st Edition:

Pp. 229-235.

5. Yan Li, MD, PhD and Robert C.G. Martin, II, MD, PhD. Apoptosis in Carcinogenesis

and Chemotherapy: Esophageal cancer. In: Apoptosis in Carcinogenesis and

Chemotherapy, Editor George G Chen, MD, PhD, 1st Edition, Springer 2009.

6. Schiffman S, Martin RCG. CT- and MR-guided Interventions in Radiology: Chapter 13

Technical basics of Microwave ablation. 2nd Edition, Springer 2011

7. Robert C.G. Martin, II, MD, PhD, Hepatocellular Cancer, Springer 2009 Editors Kelly

M. McMasters, MD, PhD and Jean-Nicholas Vauthey, MD, FACS

Chapters:

Chapter 8: Hepatocellular Carcinoma Arising in the Non-Viral, Non-Alcoholic Liver

Chapter 18: Microwave Ablation

Chapter 20: Chemoembolization with Drug-Eluting Beads

8. St. Hill CR, Brown R, Martin RCG. Video Atlas of Advanced Minimally Invasive


50

Surgery, Elsevier 2011, Editor: Mark Carlson

Chapter 17: Laparoscopic Liver Resection

9. Fouad H, Martin RCG. Regional Cancer Therapy for Advanced Tumors Jaypee

Brothers Medical Publishing, 2011, Editor: Martin Goodman

Chapter: Hepatic Arterial Therapies for Colorectal Metastases

10. Suzanne C. Schiffman, MD and Robert C.G. Martin, II, MD, PhD. Arteriovenous

Fistulae and Aneurysms of the Hepatic and Pancreatic Vasculature.In: LH Blumgart,

editor. Surgery of the Liver, Biliary Tract and Pancreas. Fifth Edition. Elsevier Health

Sciences.

11. Woodall CE, Martin RC, McMasters KM, Scoggins CR. Hepatocellular carcinoma

arising in the non-viral, non-alcoholic liver. In: McMasters KM, Vauthey JN, eds.

Hepatocellular carcinoma: Targeted therapy and multidisciplinary care. New York:

Springer, 2011:99-108.

12. Schiffman S, Martin RCG. CT- and MR-guided interventions in radiology (Chapter 13)

In:

Technical Basics of Microwave Ablation; 2nd ed. New York: Springer, 2011.

13. Philips, P, Martin RCG. Technical Considerations in Liver Surgery. Handbook of

Pancreas and Hepatobiliary Surgery, 1st Edition. Lippincott 2013.

14. Phillips P, Li Y, Martin RCG. Chapter 23: Low Energy DC currrent ablation in a

mouse tumor model. 2nd Edition of Electroporation Protocols: Preclinical and Clinical

Gene Medicine. Book: Electroporation Protocols: Preclinical and Clinical Gene

Medicine. Springer Science Business Media, New York, NY, 2014

15. Shumer E, Martin RCG. Chapter: Minimally Invasive Feeding Tube andEsophageal

Stent Placement. Book: Minimally Invasive Foregut Surgery: Principles and Practices.

2014

16. Spaulding T, Martin RCG. Chapter: Gastroienteropathic Neuroendocrine Tumors.

Book: Current Controversies in Cancer Care for the Surgeon. Springer Science and

Business Media, New York, NY 2014

OTHER PUBLICATIONS

1. Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Martin RCG,

Post-Graduate Course 16, American College of Surgeons, 88th clinical congress. Oct 6th-

10th, 2002 pg 26-28.


51

2. Martin,R.C.G., Hughes,K., Doll,M.A., Rothmann,N. and Hein,D.W. -102

polymorphism present at the -102 position from the transcription start site of the MnSOD

gene. Genebank Bankit #574003, AY397775. Homo sapiens Manganese Superoxide

Dismutase partial 5' UTR.

BOOK REVIEWS

1. Atlas of General Surgery. Am J Surg 174:570, 1997.

SPEAKER PRESENTATIONS

International:

1. DC/LC Bead Open Surgical Registry in Primary and Metastatic Liver Tumors. European

Conference of Interventional Oncology and Embolotherapy. Palazzo dei Congessi,

Florence, Italy April 10th, 2008.

2. DC/LC Bead Open Surgical Registry: The Power of A Registry. European Conference of

Interventional Oncology and Embolotherapy. Hotel Brunelleschi Florence, Italy April

11th, 2008.

3. DC/LC Bead Treatment for Neo-adjuvant for resectable and marginally resectable

Hepatocellular. International Liver Cancer Association (ILCA), Chicago, IL, September

5th, 2008.

4. DC/LC Bead Interim Analysis is Neoadjuvant Therapy for Metastatic Colorectal Cancer.

14th Congress of the European Society of Surgical Oncology, The Hague, The

Netherlands, September 10-12th, 2008.

5. LC/DC Bead Registry: Management in Metastatic and Primary Cancer of the Liver. 10th

Congress of the Cardiovascular and Interventional Radiological Society of Europe,

Copenhagen, Sweden, September 16th, 2008.

6. Toxicity of irinotecan eluting beads in the treatment of hepatic malignancies: results of

multi-institutional registry. 11th Congress of the Cardiovascular and Interventional

Radiological Society of Europe, Lisbon, Portugal September 20th, 2009.

7. Review of 350 Patient Drug Eluting Bead Registry: Breast, Melanoma,

Cholangiocarcinoma and Esophageal. 11th Congress of the Cardiovascular and

Interventional Radiological Society of Europe, Lisbon, Portugal September 20th, 2009.


52

8. Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic Non-

Thermal Ablation using irreversible electroporation (IRE): initial USA Clinical

Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary

Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

9. Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic

Thermal and Non-Thermal Ablation of the Pancrease – Past Clinical and Recent Pre-

Clinical Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary

Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

10. Pre Congress Course – Multimodality Treatment of HPB Tumors: Topic Yttrium labled

microsphers inneuroendocrine metastases. 9th World Congress of the Internation Hepato-

Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

11. Latest Clinical and Pathological result of Drug-Eluting Beads in the management of

metastatic colorectal and hepatocellular carcinoma Symposium: Topic Drug Eluting

Bead, Irinotecan (DEBIRI) Therapy of liver Metastasis from Colon Cancer with

Concomitant FOLFOX-6 and anti-Angiogenic Therapy. 9th World Congress of the

Internation Hepato-Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos

Aires, Argentina

12. Treatment of chemo naive colorectal liver metastasis by using irinotecan drug eluting

bead with concomitant systemic fluorouracil and oxaliplatin. 12th World Congress on

Gastrointestinal Cancer, June 30th – July 3rd, 2010, Barcelona, Spain

13. Current Concepts in the Treatment of Colorectal Hepatic Metastasis – ECIO meets

ESMO: Conventional Chemoembolization and Drug Eluting Beads. 2nd European

Conference on Interventional Oncology. July 21-24th, 2010, Florence, Italy

14. LC/DC Bead – How to Select Patients and Optimize Outcomes – Satellite Symposium:

DC Bead in Metastatic Disease: DEBIRI in Combination with Systemic Chemotherapy:

The optimal management of liver dominant disease. 2nd European Conference on

Interventional Oncology. July 21-24th, 2010, Florence, Italy.

15. Irreversible Electroporation: The next frontier for focal ablative therapy – Satellite

Symposium: Non-Thermal Ablation using irreversible electroporation: The initial US

Experience. 2nd European Conference on Interventional Oncology. July 21-24th, 2010,

Florence, Italy.

16. Moderator and Chairman at the Expert Meeting of Drug Eluting Bead Technology:

Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads.


53

Presentation – The Rationale for Irinotecan Drug Eluting Bead Therapy in Metastatic

Colorectal Cancer, Empire Riverside Hotel, July 26th, Hamburg, Germany.

17. Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads.

Presentation the Multidisciplinary Management of Atypical Metastatic Disease to the

Liver, Empire Riverside Hotel, July 26th, Hamburg, Germany.

18. Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Mount

Elizabeth Hospital, Singapore, September 29th, 2010.

19. Optimal Hepatic Arterial Therapy for Primary and Metastatic Disease to the Liver.

National University Hospital and Tan Tock Seng Hospital Multidisciplinary Conference,

Singapore, September 29th, 2010.

20. Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Annual

Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota Bahru, Malaysia

September 30th, 2010.

21. Optimal Combination Systemic and Hepatic Arterial Therapy in Metastic Disease to the

Liver. Annual Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota

Bahru, Malaysia, September 30th, 2010.

22. DC BeadM1 managing metastatic disease: Clinical rationale and pilot data. 12th

Congress of the Cardiovascular and Interventional Radiological Society of Europe,

Valencia, Spain October 2nd, 2010.

23. Oncology Conference and Treatment planning Conference. Novel Treatments in the

Management of Unresectable Metastatic Colorectal Cancer. Instituto Nacional de Câncer

– INCA, Rio de Janerio, Brazil, June 28th, 2011.

24. Oncology Grand Rounds The treatment of hepatic tumors, the chemoembolization, their

indications, results and applications. Hospital Santa Rita - Sta. Casa de Porto Alegre,

Brazil. June 29th, 2011

25. Oncology Tumor Board – Grand Rounds. Multi-Disciplinary Management of Metastatic

Colorectal Cancer. Hospital de Clinicas de Porto Alegre. Porto Alegre, Brazil. June 29th,

2011

26. Oncology Multi-Disciplinary Treatment Conference. Update in treatment of metastatic

tumors to the liver: Chemoembolization - indications and results. Hospital Mae de Deus,

Instituto do Cancer, HCPA, Hospital Conceicao, PUCRS. Porto Alegre, Brazil. June

29th, 2011.


54

27. Chiliean – Americas Hepato-Pancreatico-Biliary Post Graduate Course. New

Technologies for Liver-Directed Therapy: Microwave Ablation, Radioembolization and

Drug-Eluting Beads. Clinical Alemana, Santiago, Chile, July 1st, 2011.

28. Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal

Cancer. Hospital AC Carmago, Sao Paulo, Brazil, August 9th, 2011.

29. Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal

Cancer. Hospital Albert Enstein, Sao Paulo, Brazil, August 10th, 2011.

30. Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE).

Drug Eluting Beads and Transarterial Chemoembolization in HCC prior to resection and

transplant. Buzios, Brazil August 11, 2011.


Decision making strategies for resection and the role of loco regional therapies in

metastatic colorectal cancer. .Buzios, Brazil August 11, 2011.


Ablative Therapies for Metastatic Colorectal Cancer. Buzios, Brazil August 11, 2011.


Drug Eluting beads in the management of Metastatic Colorectal Cancer. Buzios, Brazil

August 11, 2011.

34. Asian Pacific HPBA Congress. The use of Irinotecan Drug Eluting Beads: A Surgeons

Perspective. Melbourne, Australia, September 29th, 2011.

35. The Interdisciplinary Treatment of Liver Tumors (ITLT) – Chairman of Session: Liver

Metastasis of Colorectal Cancer. The Atlantic Conference Center, Essen Germany,

October 29th, 2011.

36. The Interdisciplinary Treatment of Liver Tumors (ITLT) – Speaker at Session: Liver

Metastasis of Colorectal Cancer: Chemoembolization of colorectal liver metastasis:

conventional or drug eluting beads. The Atlantic Conference Center, Essen Germany,

October 29th, 2011.

37. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011 –

Munich, Germany September 18th, 2011 – Updates in Irreversible Electroporation of the

Liver and Pancreas – Results Multi-institutional Registry.


55

38. The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012

in Florence, Italy. Is there a place for local chemotherapy to the liver?

39. The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012

in Florence, Italy. Irreversible Electroporation in Locally Advanced Pancreatic Cancer.

40. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012 –

Lisbon, Portugal September 18th, 2012 – Interim results of a first-line evaluating DEBIRI

in combination with FOLFOX and Avastin in Colorectal Liver Metastasis.

41. The European Society of Surgical Oncology 32nd Congress, Valencia, Spain September

19th, 2012 – Embolic Drug Eluting Beads in the Management of Colorectal Liver

Metastasis.

42. SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario

Canada, February 1st, 2013 - Ablation Nation: Do we need new ablation technologies?

What do they add?


Canada, February 2nd, 2013 - How much liver can you take out?: Preop optimization

techniques: downstaging and PVE.


Canada, February 1st, 2013 – Sequencing of Locoregional Therapy and Chemo for HCC.

45. Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013,

Budapest, Hungary – Drug Eluting Beads in Metastatic Colorectal Cancer.

46. Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013,

Budapest, Hungary – Optimal Management in Metastatic Colorectal Cancer- Tumor

Board Discussion.

47. Chariperson – Moderator for IHPBA 11th World Congress 2014, Seoul, Korea, March

24th, 2014 – Various Issues in Colorectal Liver Metastasis

48. Invited Speaker to the IHPBA 11th World Congress 2014, Seoul Korea, March 23rd,

2014 – Session: Updates in Image-Guided and Computer-Assisted Liver Surgery –

Optimal Intra-operative navigation for Irreversible Electroporation of Locally Advanced

Pancreatic Cancer.

49. International Academic Conference on Irreversible Electroporation in Tumor Ablation.

May 10th 2014, 301 Military Hospital Beijing China. Optimal Patient Selction and


56

Outcomes for IRE in Liver and Pancreatic Tumors.

50. International Academic Conference on Irreversible Electroporation in Tumor Ablation.

May 11th 2014, Prince of Wales Hospital, Chinese Medical University, Hong Kong

China. Optimal Patient Selction and Outcomes for IRE in Liver and Pancreatic Tumors.

51. CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Pancreatic Tumors

Irreversible Electroporation.

52. CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Chair, moderator of

session - MRI Gated Focuses Ultrasound and IRE.

53. The 10th Chinese Conference of Minimally Invasive Therapy in Oncology / The 1st

Scientific Meeting of Asia Pacific Association of Imaging Guided Therapy in Oncology –

Shanghai, China, Nov 7th 2014 – IOUS-Guided Tumor Ablation – History, Current

Situation, and Future

54. 2014 Capital Ultrasound Forum / The 2nd Ultrasonic Medical Academic Conference –

Beijing, China Nov 8th 2014. – 3D Ultrasound Enhanced Imaging in Advanced Liver and

Pancreatic Ablations

55. Workshop of Intraoperative Ultrasonography in Hepatobiliary Surgery – Beijing China,

Nov 8th 2014 – Novel Intra-operative Ultrasound Techniques for Liver Ablation

National:

56. Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Post-Graduate

Course 16, 88th Congress, American College of Surgeons, San Francisco Oct 6th-10th,

2002.

57. Blood Utilization in Surgical Oncology. Ortho Biotech Surgery – Johnson and Johnson

2006 Summit, Phoenix AZ, April 2006.

58. Ablative Approaches to Pulmonary, Renal, and Bone Tumors. The Society of Surgical

Oncology Annual Meeting, San Diego, CA, March 2006.

59. Optimal Multimodality Care of Esophageal Cancer. Boston Scientific National Sales

Meeting. Orlando, FL, January 31st, 2007.

60. New Uses in Esophageal Stenting for the treatment of Esophageal Diseases: Benign and

Malignant. Boston Scientific National Marketing Meeting. Sanibel Island, FL, March

8th, 2007.


57

61. Moderator, Optimizing the Management of Anemia in Cancer Surgery. Society of

Surgical Oncology, 60th Annual Cancer Symposium, Washington, D.C., March 15th-

18th, 2007.

62. The Use of Intra-operative Auto-transfusion in Surgical Oncology: A True Contra-

indication? Society of Surgical Oncology, 60th Annual Cancer Symposium, Washington,

D.C., March 15th-18th, 2007. Invited speaker: Interventional Radiology Symposium,

Little Rock, Arkansas, May 15th, 2007: New Modalities in the Treatment of Primary and

Secondary Liver Cancer.

63. Invited speaker to the SAGES and AHPBA 2007 Scientific Session, April 18-22, 2007,

Las Vegas, NV: SAGES/ AHPBA Panel: Contemporary Issues and Outcomes: Hepatic

Tumor Ablation: The Physics of Ablation.

64. Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007,

Las Vegas, NV: remote ischemia preconditioning modulates hepatic microcirculation

through the hemeoxygenases pathway in a rat model of warm ischemia reperfusion injury

of the liver.


Las Vegas, NV: Guidelines for power and time variables for Microwave Ablation in a

porcine liver


Las Vegas, NV: Factors influencing Perioperative Blood Transfusion in Patients

undergoing Major Hepato-Pancreatico-Biliary procedures.

67. Moderator of World Congress Interventional Oncology, Washington DC in May 14-17th,

2007. RFA and Embolization for the Management of soft Tissue Malignancies: liver and

breast.

68. Invited Speaker to World Congress Interventional Oncology, Washington DC in May 14-

17th, 2007. Laparoscopic Hepatic Resections with a Novel Surgical Device: the Habib

4X

69. Invited Speaker to Huntsville Alabama, Clinical Research Meeting, July 26th, 2007. New

Hepatic Arterial Modalities in the Treatment of Primary/ Secondary Liver Cancer.

70. Invited Speaker to University of Florida, Shands, Jacksonville, Division of Surgical

Oncology Grand Rounds August 22, 2007. Novel Treatments in Esophageal

Adenocarcinoma.


58

71. Invited Speaker to University of Florida Interventional Radiology Oncology Seminar,

Gainesville, FL, September 6th, 2007. Novel Treatments in the Hepatic Intra-arterial

Therapy of the Liver.

72. Guest Faculty to Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency

Ablation, Charlotte, NC September 16-17th.

73. Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency

Ablation, Charlotte, NC September 16th. Radiofrequency Ablation for Colorectal Hepatic

Metastasis.

74. Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency

Ablation, Charlotte, NC September 17th. Microwave Ablation for Primary and

Secondary Hepatic Tumors.

75. University of North Carolina Gastroenterology Grand Rounds, September 18th, 2007.

Invited Speaker: Novel Endoscopic Therapies in Esophageal Adenocarcinoma.

76. Hulston Cancer Center Symposium, Springfield, MO, September 21st, 2007. Invited

Speaker: Advances in the Multi-Disciplinary Care of Hepatic and Pancreatic Cancers.

77. Duke University Multi-disciplinary Gastrointestinal Grand Rounds, Raleigh, NC,

October 11th, 2007. Invited Speaker: Novel Endoscopic Therapy in Esophageal

Adenocarcinoma.

78. 93rd Annual Clinical Congress of the American College of Surgeons, Current

Management of Hepatoma Session, October 10th, 2007 New Orleans, LA. Invited

Speaker: Non-operative, non-ablative therapies for hepatoma: Embolization,

chemoembolization, and radioactive microsphere treatment, systemic therapy, and more.

79. Kansas University Interventional Hepatic Therapy Grand Rounds, October 31st, 2007

Kansas City, Kansas. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and

Secondary Liver Tumors.

80. Medical College of Georgia Department of Surgery, Upper Gastrointestinal Multi-

disciplinary Grand Rounds, November 2, 2007, Augusta, GA. Invited Speaker: Novel

Endoscopic Therapies in Esophageal Adenocarcinoma.

81. St. Clare Regional Hospital/ Thompson Cancer Center Grand Rounds, November 12th,

2007, Knoxville, TN. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and

Secondary Liver Tumors.


59

82. Tampa General Hospital Interventional Radiology Department, Cancer Conference,

November 15th, 2007, Tampa, FL. Invited Speaker: Recent Advances in TransArterial

Embolization for Primary and Metastatic Liver Cancer.

83. Piedmont Hospital System Tumor Board, Cancer Conference, November 28th, 2007,

Atlanta, GA. Invited Speaker: Recent Advances in TransArterial Embolization for

Primary and Metastatic Liver Cancer.

84. Trinity Hospitals Tumor Board, Cancer Conference, December 13th, 2007, Minot, ND.

Invited Speaker: Advances in the Surgical Quality of Colon Cancer.

85. The Society of Surgical Oncology 61st Annual Cancer Symposium, March 13th Sheraton

Chicago Hotel, Chicago, IL. Microwave Ablation of Liver Tumors: Results of Clinical

Trials.

86. Louisiana State University, Cancer Conference, May 14th, 2008, Shreveport, LA.

Invited Speaker: Advances in Hepatic Arterial Therapy for Primary and Metastatic Liver

Cancer.

87. Distinguished Speaker: Contrast Enhanced Hepatic Ultrasound, B-K Medical Systems

Colon Rectal Focus Group, Kennebunkport, ME, August 9-10th, 2008.

88. Mount Sinai Medical Center / Miami Heart Institute, October 3rd, 2008, Miami, FL.,

Invited Speaker, Tumor Board: Interim Analysis of International LC/DC Bead Registry

for Primary and Metastatic Lesions to the Liver.

89. Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA,

Clinical Dilemmas in Cancer Surgery: Vascular Resections in Pancreatic Cancer


Clinical Dilemmas in Cancer Surgery: Laparoscopic Resection of Liver Tumors


Clinical Dilemmas in Cancer Surgery: Treatment of Unresectable Liver Tumors:

Radiofrequency and Microwave Ablation, Intra-arterial Radiotherapy and Chemotherapy

92. The Association for Academic Surgery – Fall Leadership Course, October 10th, 2009,

Chicago, IL - Choosing the Right Job and Negotiating for Academic Success

93. The Academic Surgical Congress: Hot Topic Symposium: Liver Tumors: Expert Update:

Treating Primary and Secondary Hepatic Malignanices with Radiofrequency or


60

Microwave Ablation: Patient Selection and Outcomes. February 5th, 2010, San Antonio,

TX.

94. The Academic Surgical Congress: Instructor: Animate Hands-on Session: Beginner and

Advanced Liver Ultrasound Modules. February 5th, 2010, San Antonio, TX.

95. The Society of Surgical Oncology: Symposium Speaker: Optimizing Outcomes in

Metastatic Gastrointestinal Neuroendocrine Tumors. March 7th, 2010, St. Louis, Mo

96. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Electroporation: Which

Patients and Why? Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24, 2011

97. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. All These Interventional

Options: Where Does the Surgeon Fit In? – Philosophical Concepts? Encore at Wynn

Las Vegas, La Vegas, Nevada Sept 23-24, 2011

98. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Cancer Therapies: A

Multidisciplinary Approach. Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24,

2011.

99. The 97th American College of Surgeons Annual Meeting – Moderator - Management of

Complex Cancers: Upper GI Tumors. Moscone Center, San Francisco, CA October 25th,

2011.

100. The 97th American College of Surgeons Annual Meeting – Speaker- Management of

Complex Cancers: Upper GI Tumors. Topic Surgical Management of GI Neurendocrine

Tumors. Moscone Center, San Francisco, CA, October 25th, 2011.

101. Updates in Ablation Therapy – Thermal to Non-Thermal Modalities. Dekalb Angio Club,

Atlanta, GA, November 8th, 2011.

102. Irreversible Electroporation – Initial Results in the treatment of locally advanced

pancreatic cancer – planned Phase II Trial. AHPBA National Meeting, Eden Roc, Miami

FL., March 7th, 2012.

103. Optimal management of metastatic neuroendocrine tumors with oral-targeted agents and

long-acting injection. 65th Annual Cancer Symposium – Society of Surgical Oncology,

Orlando World Congress, Orlando, FL, March 22nd 2012.

104. Surgery for Non-Invasive Disease: Does it Save Lives? Barrett’s Esophagus. 65th Annual

Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando,

FL, March 22nd 2012.


61

105. Interactive Tumor Board – Colorectal Cancer – with and without Liver metastasis. 65th

Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress,

Orlando, FL, March 24nd 2012.

106. Analogic Investor Education Day – NASDAQ – “Ultrasound Guidance – Essential Tool

in the Operating Room”. October 4, 2012, New York, NY.

107. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local

Control and Quality of Life: Department of Surgery Grand Rounds – Wake Forest

University – Bowman Grey Hospital, Winston Salem NC, October 31st 2012.

108. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local

Control and Quality of Life: Department of Surgery Carolinas Medical Center, Charlotte,

NC, October 31st 2012.

109. Current Trial in DEBIRI. SYNERGY 2012: A Multidisciplinary Approach to

Interventional Oncology, Miami, FL. November 10th, 2012.

110. Surgical Ablation of Pancreatic Cancer. SYNERGY 2012: A Multidisciplinary Approach

to Interventional Oncology, Miami, FL. November 11th, 2012.

111. Ultrasound Methods of Tumor Ablation in HPB Surgery. AHPBA National Meeting,

Eden Roc, Miami FL., February 20th, 2013.

112. What Are The Most Important Clinical Questions? How to Access What is Most

Relevant to our Members. AHPBA National Meeting, Eden Roc, Miami FL., February

22th, 2013.

113. Predictors of Readmission and Quality Parameters in Liver Surgery. AHPBA National

Meeting, Eden Roc, Miami FL., February 22th, 2013.

114. Safety of Hepatectomy after Yttrium-90 Therapy. AHPBA National Meeting, Eden Roc,

Miami FL., February 22th, 2013.

115. Electroporation of Liver and Pancreas: Still Experimental or Accepted Practice? A

Opinion. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.

116. Advanced energy/laparoscopy in Pancreatic – Esophagogastric Surgery. 66th Annual

Society of Surgical Oncology Caner Symposium. New Harbor MD, March 7th, 2013

117. STATE OF THE ART CONFERENCE: Pancreas – 54th Annual Meeting – The Society


62

for Surgery of the Alimentary Tract, May 19th, 2013, Orlando Fl. The Use of Irreversible

Electroporation in Unresectable Pancreatic Cancer.

118. Hepatic Tumor Ablation Technologies – 2nd Annual AHPBA Fellows Minimally

Invasive Surgery Course – August 19th, 2013

119. Laparoscopic Pancreatic Resection - 2nd Annual AHPBA Fellows Minimally Invasive

Surgery Course – August 19th, 2013

120. DEBIRI – Update on Clinical Trials and Results, 3rd Annual SYNERGY Meeting, Eden

Roc, FL – October 19th 2013

121. Margin Accentuation in Pancreatic Cancer – Results and Outcomes, 3rd Annual

SYNERGY meeting, Eden Roc Fl, October 19, 2013

122. Surgical Management of Metastatic Colorectal Trials and Metastatic Neuroendocrine

Tumors. Symposium on the Management of Liver Metastasis, Methodist Dallas Medical

Center / Methodist Health System Clinical Research Institute, October 26th, 2013

123. Ultrasound Methods in Tumor Ablation – 2014 Annual Meeting Americas Hepato-

Pancreatico-Biliary Association, Eden Roc, Miami FL.

124. US Coding and Billing for the Surgeon - – 2014 Annual Meeting Americas Hepato-

Pancreatico-Biliary Association, Eden Roc, Miami FL.

125. Surgical Management of GI Neurendocrine Tumors – 2014 Annual Scientific Meeting,

February 22nd 2014 – Southeastern Surgical Congress.

126. Invited Moderator – Pancreas and GI Session -Society of Surgical Oncology 67th Annual

Cancer Symposium – Phoenix, Az – March 15th 2014

127. Invited Speaker – Session Surgeon Directed Tumor Ablation - Society of Surgical

Oncology 67th Annual Cancer Symposium – Phoenix, Az – March 12th 2014 –

Advances of IRE in Pancreas.

128. Invited Speaker – Session Metastatic Colorectal Cancer – Synergy 2014 – A

Multidisciplinary Effect to Interventional Oncology November 15th 2014 – Irinotecan

Loaded Beads for the Treatment of Unresectable Colorectal Liver Metastasis

129. Invited Speaker – Session Pancreas – Synergy 2014 - A Multidisciplinary Effect to

Interventional Oncology November 16th 2014 – Resistance as a Measure of Successful Tumor

Electroporation during IRE of the Pancreas


63

130. Invited Disccussant – Western Surgical Association 2014 Annual Meeting, Indian Wells CA,

Nov 11th - Is Liver Transplantation Appropriate for Patients with Potentially Resectable de novo

Hilar Cholangiocarcinoma?

Regional:

131. Neoadjuvant Therapies in Esophageal Cancer. Central Baptist Hospital Oncology

Research Symposium, Lexington, KY. July 27th, 2006.

132. Surgical Management of Gastric and Distal Esophageal Lesions. Kentucky Medical

Association Annual Meeting, Kentucky Chapter, American College of Surgeons,

September 10th, 2003.

133. Advances in Hepatic Tumor Ablations. Central Surgical Association Louisville, KY.

March 2006.

134. Moderator, American Hepato-Pancreatico-Biliary Association Meeting, Hepatic and

Pancreatic Free Paper Session, Eden Roc Hotel, Miami, Florida, March 11th, 2006

135. Surgical Treatment of Malignant Liver Tumors: Resection and Ablative Options.

Southern Society of Clinical Surgeons, Louisville, KY, April 10th, 2006.

136. Optimal Management for Colorectal Cancer: Multi-disciplinary Care. Grand Rounds

Seymour, Indiana Cancer Center, October 5th, 2006.

137. Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced

Staged Colon Cancer. Hurley Medical Center Tumor Board, Flint MI, Jan 17th, 2007


Staged Colon Cancer. Saginaw Medical Specialist Multidisciplinary Meeting, Saginaw,

MI Jan 17th, 2007.


Staged Colon Cancer. Utley Medical Center, Lafayette, IN, Jan 25th, 2007


Staged Colon Cancer. Fort Wayne Medical Oncology Meeting, Fort Wayne, IN, Jan 25th

2007.


64

141. Optimal Surgical Management of Stage III and Stage IV colorectal cancer. Parkview

Hospital Tumor Board, Ft Wayne, IN May 2007.

142. Options for Localized Hepatocellular Cancer: Irreversible Electroporation. 2014

Hepatocellular Carcinoma: Advances and Challenges for Rapidly Increasing Malignancy.

University of Cincinnati, Cincinnati OH, Sept 27th, 2014.

Local:

143. Synchronous Colorectal Metastasis: Staged vs Simultaneous Resection? Surgical Grand

Rounds Memorial Sloan-Kettering Cancer Center, March 11th, 2002.

144. Surgical Management of Primary Liver Tumors. University of Louisville Department of

Surgery Grand Rounds, November 15th, 2002.

145. Cancer of the Pancreas. University of Louisville Department of Surgery Grand Rounds,

August 15th, 2003.

146. IntraOperative MRI Guided Liver Tumor Ablation. Second Annual IntraOperative MRI

Symposium. Norton Hospital Cancer Center, November 8th, 2003.

147. Surgical Therapy in Barrett’s Esophagus. Barrett’s Esophagus Symposium, Louisville,

KY. November 13th, 2004.

148. Tumors of the Pancreas: Diagnosis and Management. University of Louisville Surgical

Grand Rounds. Louisville, KY, February 21st, 2006.

149. Advances in the Surgical Treatment of Cancer. Second Annual Louisville Update in

Oncology, ASCO Review, Louisville, KY, July 15th, 2006.

150. Update on the Treatment of Liver Tumors. Kentucky Chapter American College of

Surgeons, Fall Meeting Sept 15th-16th, 2006.

151. Advances in Liver and Pancreatic Tumor Treatments. Norton Healthcare Perioperative

Symposium Sept 9th, 2006.

152. Management of Pancreatic Cancer. 6th Annual CEU Roundtable Conference for

Healthcare Professionals, October 12th, 2006.

153. University of Louisville Grand Rounds. Benign Liver Tumors and their Management.

October 20, 2006.


65

154. Gastroenterology/ Hepatology Teaching Conference. Advances in Barrett’s Esophagus

Basic Science Research. November 9th, 2006.

155. Pikeville Osteopathic School. Clinical Continutiy Lecture for 1st and 2nd year osteopathic

students. What is Cancer? How do you prevent it? November 17th, 2006.

156. Multimodality Gastrointestinal Cancers University of Louisville, James Graham Brown

Cancer Center. Surgical Managagement of Metastatic Gastrointestinal Cancers: Can it be

Curative? November 18th, 2006.

157. University of Louisville Department of Surgery Grand Rounds. Barrett’s Esophagus

August 24th, 2007.

158. University of Louisville, James Graham Brown Cancer Center, ASCO Review – Update

in Oncology, September 8, 2007. Advances in Upper Gastrointestinal and Hepato-

Pancreatico-Biliary Malignancies.

159. University of Louisville, Jewish Hospital, Advances in Laparoscopic Hepato Pancreatico

Biliary Surgery, September 14th, 2007. Outcomes in Laparoscopic Hepato Pancreatico

Biliary Surgery.

160. University of Louisville, James Graham Brown Cancer Center, 2nd Annual

Gastrointestinal and Hepato-Pancreatico-Biliary Multidisciplinary Conference, October

27th, 2007. Invited Speaker: Surgical Treatment in Pancreatic Cancer: Current State of the

Art.

161. Kentucky Chapter of the American College of Surgeons Meeting, November 3rd, 2007,

Louisville, Ky. Invited Speaker, Advances in Minimally Invasive Treatment of Liver

Tumors.

162. Norton Healthcare Endoscopy Symposium, November 15th, 2008, Louisville, Ky. Invited

Speaker, Advances in Esophageal Stenting for Esophageal Strictures: Benign and

Malignant.

163. First and Second Year Surgical Club University of Louisville, Olmstead, Louisville Ky,

October 14th 2013. Invited Speaker – Perspectives on a Career in Surgical Oncology.

164. Radiation Oncology Grand Rounds - Advances in locally advanced pancreatic cancer:

Optimal Palliation and Improved Quality of Life Time. Sept 26th, 2014.

Abstract Presentations:


66

1. Microbial Expression of the Human Estrogen Receptor Gene: Comparison of the Receptor

Protein with that of Human Breast Cancer. Poster Presentation, University of Louisville

Research Day, Louisville, KY, May 1992.

2. Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical

Patients. Oral Presentation, Louisville Surgical Society, Louisville, KY, February 1997.

3. Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical

Patients. Oral Presentation, Kentucky Chapter of the American College of Surgeons,

Lexington, KY, April 1997. Winner Resident Paper Competition.

4. Initial Neck Exploration in Untreated Hyperparathyroidism. Poster presentation,

Southeastern Surgical Congress, Tampa, FL, February 1999.

5. The Use of Intraoperative Methylene Blue in Parathyroid Resection. Poster Presentation,

Southeastern Surgical Congress, Tampa, FL, February 1999.

6. Initial Neck Explorations in Untreated Hyperparathyroidism. Oral Presentation, Louisville

Surgical Society, Louisville, KY, March 1999.

7. Special Problems in the Surgical Care of the Melanoma Patient. Oral Presentation,

Kentucky Chapter of the American College of Surgeons, Louisville, KY, May 1999.

8. Cost Comparison of Endoscopic Stenting versus Surgical Treatment for Unresectable

Cholangiocarcinoma. Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ,

McMasters KM. Poster presentation, Society of American Gastrointestinal Endoscopic

Surgeons, Atlanta, GA, March 29-April 1, 2000.

9. Optimal Gamma Probe Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a

Nationwide Multi-Institutional Study. Martin RCG, McMasters KM, Wong SL, Tuttle TM,

Edwards MJ. Oral Presentation, Kentucky Chapter of the American College of Surgeons,

Lexington, KY, March 2000. Louisville Surgical Society, Louisville, KY, April 2000.

Winner of the Resident Paper Competition.

10. A Microsatellite Marker for Colorectal Cancer Associated with the Human MSH2 Gene.

Martin RCG, Hunt LE, Eichenberger MR, Galandiuk S. Kentucky Chapter of the

American College of Surgeons, Lexington, KY, March 2000.

11. Do Facial Fractures Protect the Brain or Are They a Marker for Severe Head Injury?

Martin RCG, Cerrito P, Spain DA, Richardson JD. Oral Presentation, 108th Annual

Scientific Session of the Western Surgical Association, Dana Point, CA, November 12-15,


67

2000.

12. The Quality of Complication Reporting in the Surgical Literature. Martin RCG, Brennan

MF, Jaques DJ. Oral presentation, Southern Surgical Association, Hot Springs, VA,

December 2001.

13. Randomized Control Trials: Does Additional Training Increase Participation? Martin

RCG, Brennan MF, Polk HC Jr, Jaques DJ. Oral presentation, The American College of

Surgeons Clinical Congress, New Orleans, LA. October 2001.

14. Highest Isotope Count Does Not Predict Sentinel Node Positivity in all Breast Cancer

Patients. Martin RCG, Fey J, Borgen PI, Cody HS. Oral Presentation, Society of Surgical

Oncology, Washington, DC, March 15-18, 2001.

15. Solid-Pseudo Papillary Tumors of the Pancreas: A Surgical Enigma. Martin RCG,

Klimstra D, Brennan MF, Conlon KC. Poster presentation, Society of Surgical Oncology,

Washington, DC, March 15-18, 2001.

16. Extended Local Resection for Advanced Gastric Cancer: Increased Survival vs Increased

Morbidity? Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Oral Presentation,

International Congress of Gastric Cancer, New York, N.Y., April 30-May 2, 2001.

17. Achieving R0 Resection for Locally Advanced Gastric Cancer: Is it Worth the Risk for

Multi-Organ Resection? Martin RCG, Brennan MF, Leung D, Karpeh, M. Poster

Presentation, Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.

18. Peritoneal Washings are not Predictive of Advanced Stage in Hilar Cholangiocarcinoma.

Martin RCG, Fong Y, Dermatteo RP, Blumgart LH, Jarnagin WR. Poster Presentation,

Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.

19. Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? Martin RCG,

Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart LH. Oral

Presentation, Paper Session I, 88th congress, American College of Surgeons, San Francisco

Oct 6th-10th, 2002.

20. Management of Colorectal Metastasis. Martin RCG, Brown Cancer Center Tumor

Conference, November 6th, 2002.

21. Surgical Exposure For Partial Hepatectomy: Is There a Difference in Complications From

Chevron versus Hockey Stisk Incision? Martin RCG, Cohen MS, Ben-Porat L, Goen M,

DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR . Poster Presentation, SSAT 2003


68

22. Martin RCG, Fong Y, Dematteo RP, Jarnagin WR, Blumgart LH. Major hepatectomy

with simultaneous pancreatectomy for advanced hepatobiliary cancer. Oral Presentation,

American Hepato-Pancreato-Biliary Congress, Feb 27-March2, 2003, Miami, FL.

23. Martin RCG, McMasters KM. The Use of Intra-Operative MRI with Ablation of Hepatic

Malignancies. Video Session, 56th Annual Cancer Symposium, March5-9, 2003, Los

Angeles CA.

24. Casos S, Martin RCG, McMasters KM. Advances in Hepatic Imaging. Video Session, 56th

Annual Cancer Symposium, March 5-9, 2003, Los Angeles CA.

25. Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N

Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese

superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation,

SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology, American

Association of Cancer Research, September 13-17, 2003, Key Biscayne, FL


Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese

superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation,

James Graham Brown Cancer Center Retreat, September 17th, The Olmstead, Louisville,

KY.


Rothman and DW Hein. Association between the Manganese Superoxide Dismutase Gene

(-9 T>C) polymorphism and gastric cancer. Poster Presentation, James Graham Brown

Cancer Center Retreat, September 17th, The Olmstead, Louisville, KY.

28. Martin RCG, Hughes K, Doll MA, Lang Q, Chow W, Lissowska J, Zatonski W, Rothman

N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102)

Genotypes and Risk of Gastric Cancer. American Association for Cancer Research, 95th

Annual Meeting, March 27-31, 2004, Orlando, Florida.

29. Li Y, Martin RC, Ellis SE, Ray M, Wo JM. A Novel External Esophageal Perfusion Rat

Model for Reflux Esophagitis. AGA Poster Session, Digestive Disease Week, New

Orleans, Louisiana, May 15-20, 2004 .

30. Martin RC, Edwards MJ, McMasters KM. Initial Experience with Hepatic Arterial Infusion

Pump Chemotherapy to the Liver. Oral Presentation. The Southwestern Surgical Congress,

Monterray, CA, April 18th-21st, 2004.

31. Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of


69

Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Oral

Presentation. 6th World Congress of the International Hepato-Pancreato-Biliary

Association, Washington, DC, June 2-6, 2004.

32. Martin RC, Casos S, Chao C, Wong SL, McMasters KM. Prolonged Survival after

Radiofrequency Ablation of Synchronous Colorectal Liver Metastases. Published ASCO

Proceedings. 2004 Annual Meeting of the American Society of Clinical Oncology, New

Orleans, LA, June 5-8, 2004.

33. Martin RCG, Li Y, Hein D. Expression of NAT1 and NAT2 in Human Normal Lung and

Bronchial Carcinoma. Third International Workshop on Arylamine N-Acetyltransferases,

Vancouver Canada, August 27-28th, 2004.

34. Martin RCG. The Big C: Cancer Prevention and Detection. The Third Annual Celebrating

Women 2004 Conference, Louisville, Ky. Sept 24th, 2004.

35. Martin RCG, Evaluation of Topical Recombinant Human Thrombin is a Phase 2 study in

patients Undergoing Hepatic Resection. Poster Presentation American College of Surgeons

Annual Meeting, San Francisco October 2005.

36. Helm CW, Martin RS III, Metzinger D, Parker L, Gordinier E, Edwards R. Hyperthermic

Intraperitoneal chemotherapy with surgery for recurrent ovarian carcinoma. Society of

Gynecologic Oncology Meeting, Palm Springs, CA, March 2006. Gyn Onc 2006, vol. 101,

Supplement 1, pg. 174-175.

37. Martin RCG, Lewis AM, Scoggins CR, Stromberg, AJ, Ellis SF, McMasters KM. Health

related quality of life: Return to baseline after major and minor liver resection.

International Hepato-Pancreato-Biliary Association 2006 Congress, Edinburgh, Scotland,

Sept 3rd-7th.

38. First Author Oral Presentation SAGES 2007 2007 Scientific Session, April 18-22, 2007,

Las Vegas, NV: The Use of Self Expanding Silicone Stents in Esophageal Cancer Care:

Optimal Pre-operative, Peri-operative, and Post-operative care.

39. First Author Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las

Vegas, NV: Microwave Hepatic Tumor Ablation Results of ongoing Phase 2 Trial.

40. Senior Author Oral Presentation at the 115th Scientific Session, Western Surgical

Association, Boulder, CO, Nov 2007 Analysis of 900 Appendiceal Carcinoid Tumors with

a Proposal for a Staging System.

41. First Author Oral Presentaiton at the 115th Scientific Session, Western Surgical


70

Association, Boulder, CO, Nov 2007 Arterial and Venous Resection for Locally Advanced

Pancreatic Malignancies: Operative and Long-term Outcomes.

42. First Author Oral Presentation Society of Interventional Radiology Oncology Session,

Washington, DC March 19th, 2008: Transarterial Chemoembolization of Metastatic

Colorectal Carcinoma with Drug Eluting Beads: Multi-Institutional Study.

43. Senior Author Oral Presentation at the 116th Scientific Session, Western Surgical

Association, Sante Fe, N.M., Nov 11th, 2008. Evaluation of 2,537 Gastrointestinal Stromal

Tumors for a Proposed Clinical Staging System.

44. First Author Oral Presentation – Southern Surgical Assocation, December, 2008, The

Breakers, West Palm Beach, FL. Simultaneous vs. Staged Resection for Synchronous

Colorectal Cancer Liver Metastases.

45. First Author Oral Presentation at the 95th Annual Clinical Congress – American College of

Surgeons, October 12th, 2009, Chicago IL. Analysis of 6,747 Pancreatic Neuroendocrine

Tumors for a Proposed Staging System

46. First Author Oral Presentation – Southern Surgical Assocation, December, 2009, The

Homestead, Hot Springs VA. Laparoscopic Hepatic Lobectomy: Advantages of A

Minimally Invasive Approach.

47. Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010,

Phase II comparison study of intraoperative autotransfusion for major oncologic

procedures.

48. Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010,

Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable

Intrahepatic Cholangiocarcinoma: Optimal Tolerance and Prolonged Overall Survival.

49. Senior Author Oral Presentation – The Central Surgical Association, March 13th, 2010,

Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest

Radiography.

50. First Author Oral Poster Presentation - Treatment of chemo naive colorectal liver

metastasis by using irinotecan drug eluting bead with concomiotant systemic fluorouracil

and oxaliplatin. 12th World Congress on Gastrointestinal Cancer, June 30th – July 3rd,

2010, Barcelona, Spain.

51. First Author Presentation - Management of diffuse hepatocellular cancer (≥ 10 lesions)

with doxorubicin-loaded DC Bead is a safe and effective treatment option. 12th Congress


71

of the Cardiovascular and Interventional Radiological Society of Europe, Valencia, Spain

October 2nd, 2010.

52. First Author Oral Presentation - Optimal technique of doxorubicin DC Bead in

Hepatocellular cancer: small bead vs. large bead, one vial vs. two vials, complete stasis vs.

partial stasis. 12th Congress of the Cardiovascular and Interventional Radiological Society

of Europe, Valencia, Spain October 2nd, 2010.

53. Senior Author Oral Presentation – The Southern Surgical Association, Dec 6th, 2010, The

Breakers, West Palm Beach, Fl. A Prospective Phase II Evaluation of Esophageal Stenting

for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety

54. First Author Oral Presentation – The American Surgical Association, April 15th, 2011, The

Boca Raton Resort and Spa, Boca Raton, Fl. Readmission Rates after Abdominal Surgery:

The Role of Surgeon, Primary Caregiver, Home Health, and Sub-acute Rehab

55. Senior Author Oral Presentation - Asian Pacific HPBA Congress, September 28th, 2011

Melbourne, Australia. Laparoscopic versus Open Resection of Hepatic Colorectal

Metastases.

56. First Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical

Oncology, Orlando World Congress, Orlando, FL, March 23nd 2012. Image Guided

Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Overall

Survival.

57. Senior Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical

Oncology, Orlando World Congress, Orlando, FL, March 24nd 2012. A Deviation Based

Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection.

58. Senior Author Oral Presentation - 69th Annual Meeting of the Central Surgical Association

at the Monona Terrace Convention Center in Madison, WI, March 1st, 2012. Laparoscopic

Versus Open Resection of Hepatic Colorectal Metastases

59. Senior Author Oral Presentation – 2012 AHPBA Annual Meeting, Eden Roc Resort,

Miami FL, March 7th 2012. Safety and Early Efficacy of Irreversible Electroporation for

Hepatic Tumors in Proximity to Vital Structures.

60. Senior Author Oral Presentation – 2012 Southern Surgical Association, The Breakers, Palm

Beach, FL, Dec 4th, 2012. The Assessment of Chemotherapy Response in Colorectal Liver

Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic

Residual Viable Tumor.


72

61. Senior Author Oral Presentation – 2013 Southeastern Surgical Congress, Jacksonville, FL,

Feb 12th, 2013. Evaluation of AFP Staging System for Hepatocellular Carcinoma in Non-

cirrhotic Patients.

62. Senior Author Oral Presentation – 66th Annual Society of Surgical Oncology Cancer

Symposium, New Harbor MD, March 8, 2013. Optimal Stroke Volume Variation in

Hepatic Resection: A replacement for standard central venous pressure monitoring.

63. Senior Author Oral Presentation – Central Surgical Association, Amelia Island, FL, March

15th, 2013. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical

Efficacy or Limited Benefit?

64. Senior Author Oral Presentation – Western Surgical Association, Salt Lake Utah,

November 5th, 2013 - Single Stage Resection Combined with Microwave Ablation (MW)

for the Treatment of Bilobar Colorectal Cancer Metastases: Results from 201 Consecutive

Patients compared to two-stage Hepatectomy

65. First/ Senior Author Oral Plenary Presentation – 2014 Gastrointestinal Cancer Symposium

(giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan Drug Eluting

Beads with Simultaneous FOLFOX and Bevacizamab for patients with Unresectable

Colorectal Liver-Limited Metastasis.

66. First/ Senior Author Poster Plenary Presentation – 2014 Gastrointestinal Cancer

Symposium (giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan

Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients with

Unresectable Colorectal Liver-Limited Metastasis.

67. First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional

Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Differences in

toxicity amongst drugs used in hyperthermic intraperitoneal chemotherapy

68. First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional

Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Quality of Life

(QOL) Improvement and Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicin-

loaded beads(DEBDOX) in the treatment of liver metastases from Ocular Melanoma:

Results from a Phase I Trial.

69. First Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –

February 22, 2014 – En Roc, Miami FL. Ongoing Clinical Trial - Drug-Eluting Bead,

Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with

Concomitant Systemic Gemcitabine and Cisplatin (Gem-Cis).


73

70. Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –

February 21st 2014 – En Roc, Miami FL. The role of hepatic artery lymph node (HALN) in

pancreatic adenocarcinoma: Prognostic factor or Surgical selection criteria.

71. Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –

February 21st 2014 – En Roc, Miami FL. Laparoscopic Hepatectomy Significantly

Shortens the Time to Postoperative Chemotherapy in Obese Patients Undergoing Major

Hepatectomies.

72. Senior Author Presentation – 2014 Annual Meeting Society of University Surgeons –

February 6th 2014 – San Diego, CA - Intra-operative Navigation of a 3-Dimensional

Needle Localization System for Precision of Irreversible Electroporation Needles in

Locally Advanced Pancreatic Cancer.

73. Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014

-Southeastern Surgical Congress -Restrictive Blood Transfusion Protocol in Liver

Resections Patients Reduces Blood Transfusions with No Increase in Patient Morbidity

74. Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014

– Southeastern Surgical Congress - GERD-Related Symptom Assessment in Subjects with

Malignant Dysphagia receiving Esophageal Stents.

75. Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st

Annual Meeting, March 7th 2014, Indianapolis IN. A Cost Analysis of a Pancreatic Cancer

Screening Protocol in High-Risk Populations.

76. Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st

Annual Meeting, March 7th 2014, Indianapolis IN. Borderline and Locally Advanced

Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin

Accentuation.

77. First/ Senior Author Oral Presentation – Society of Surgical Oncology 67th Annual Cancer

Symposium – Phoenix, AZ – March 13th 2014 - Quality of Life (QOL) Improvement and

Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicin-loaded beads(DEBDOX)

in the treatment of liver metastases from Ocular Melanoma: Results from a Phase I Trial.

78. First/ Senior Author Plenary Presentation – Society of Surgical Oncology 67th Annual

Cancer Symposium – Phoenix, AZ – March 14th 2014 - Randomized Controlled Trial of

Irinotecan Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients

with Unresectable Colorectal Liver-Limited Metastasis.


74

79. Senior Author Oral Presentation - Society of Surgical Oncology 67th Annual Cancer

Symposium – Phoenix, AZ – March 14th 2014 Optimal Staging of Pancreatic

Neuroendocrine Tumors: Mandatory Grading using Ki67 Index and Mitotic Rate Increases

the Prognostic Accuracy of Disease-free Survival and Overall Survival

80. Senior Author Oral Presentation - Gastric-Esophageal Stenting for Malignant Dysphagia:

Results of Prospective Clinical Trial Evaluation of Long Term Gastro-Esophageal Reflux

and Quality of Life Related Symptoms – Western Surgical Association 2014 Annual

Meeting – Indian Wells, CA Nov 11th 2014

CURRICULUM VITAE January 5th, 2014

Documents

Transcript of CURRICULUM VITAE January 5th, 2014